# EDGAR Filing Document

**Accession Number:** 0002016072
**File Stem:** 0001213900-26-068287
**Filing Date:** 2026-6
**Character Count:** 201493
**Document Hash:** 583dea169fdb028e9aff11853c71c84f
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0001213900-26-068287.hdr.sgml**: 20260612

**ACCESSION NUMBER**: 0001213900-26-068287

**CONFORMED SUBMISSION TYPE**: 8-K

**PUBLIC DOCUMENT COUNT**: 21

**CONFORMED PERIOD OF REPORT**: 20260612

**ITEM INFORMATION**: Entry into a Material Definitive Agreement

**ITEM INFORMATION**: Termination of a Material Definitive Agreement

**ITEM INFORMATION**: Other Events

**ITEM INFORMATION**: Financial Statements and Exhibits

**FILED AS OF DATE**: 20260612

**DATE AS OF CHANGE**: 20260612

**FILER**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** M3-Brigade Acquisition V Corp.
- **CENTRAL INDEX KEY:** 0002016072
- **STANDARD INDUSTRIAL CLASSIFICATION:** BLANK CHECKS [6770]
- **ORGANIZATION NAME:** 05 Real Estate & Construction
- **EIN:** 981781141
- **STATE OF INCORPORATION:** E9
- **FISCAL YEAR END:** 1231

**FILING VALUES:**
- **FORM TYPE:** 8-K
- **SEC ACT:** 1934 Act
- **SEC FILE NUMBER:** 001-42171
- **FILM NUMBER:** 261087095

**BUSINESS ADDRESS:**
- **STREET 1:** 1700 BROADWAY, 19TH FLOOR
- **CITY:** NEW YORK
- **STATE:** NY
- **ZIP:** 10019
- **BUSINESS PHONE:** 212-202-2200

**MAIL ADDRESS:**
- **STREET 1:** 1700 BROADWAY, 19TH FLOOR
- **CITY:** NEW YORK
- **STATE:** NY
- **ZIP:** 10019

?xml version='1.0' encoding='ASCII'?

**UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549**

**FORM 8-K**

**CURRENT REPORT**

**PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934**

Date of Report (Date of earliest event reported): **June 12, 2026**

**M3-BRIGADE ACQUISITION V CORP.** *(Exact name of registrant as specified in its charter)*

---

| | | |
|:---|:---|:---|
| **Cayman Islands** | **001-42171** | **98-1781141** |
| *(State or other jurisdiction <br> of incorporation)* | *(Commission File Number)* | *(I.R.S. Employer<br> Identification No.)* |

---

---

| | |
|:---|:---|
| **1700 Broadway, 19th Floor<br> New York, New York** | **10019** |
| *(Address of principal executive offices)* | *(Zip Code)* |

---

**(212) 202-2200**

*(Registrant's telephone number, including area code)*

**Not Applicable**

*(Former name or former address, if changed since last report)*

Check the appropriate box below if the Form 8-K is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

☒ Written
communication pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

☐ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

☐ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

☐ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Securities registered pursuant to Section 12(b) of the Act:

---

| | | |
|:---|:---|:---|
| **Title of each class** | **Trading Symbol(s)** | **Name of each exchange on which registered** |
| **Class A ordinary shares, par value $0.0001 per share** | **MBAV** | **The Nasdaq Stock Market LLC** |
| **Units, each consisting of one Class A ordinary share and one-half of one redeemable warrant** | **MBAVU** | **The Nasdaq Stock Market LLC** |
| **Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50 per share** | **MBAVW** | **The Nasdaq Stock Market LLC** |

---

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

Emerging growth company ☒

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

**Item 1.01. Entry into a Material Definitive Agreement.**

Since the announcement of the proposed merger between ReserveOne, Inc., a Delaware corporation ("**ReserveOne**") and M3-Brigade Acquisition V Corp., a Cayman Islands exempted company incorporated with limited liability (the "**Company**") in July 2025, market conditions impacting the digital asset sector have changed significantly. Following careful consideration of current market dynamics and feedback from investors and other stakeholders, ReserveOne, Inc., and the Company have mutually agreed to (a) terminate the Business Combination Agreement, dated as of July 7, 2025 (the "**BCA**") by and among (i) the Company, (ii) ReserveOne, (iii) ReserveOne Holdings, Inc., a Delaware corporation and a wholly owned subsidiary of ReserveOne ("**Pubco**"), (iv) R1 SPAC Merger Sub, Inc., a Delaware corporation and a wholly owned subsidiary of Pubco, and (v) R1 Company Merger Sub, Inc., a Delaware corporation and a wholly owned subsidiary of Pubco, pursuant to Section 7.1(a) of the BCA (other than certain customary limited provisions that survive the termination pursuant to the terms of the BCA), and (b) engage in the transactions described below in order to provide the Company with additional time to identify and complete a business combination, as well as funding for working capital and payment of certain liabilities. As part of the process, the Company will solicit shareholder approval in connection with a shareholder meeting to extend its business combination period for one additional year from August 2, 2026 to August 2, 2027.

**Mutual Termination Agreement**

On June 12, 2026, the Company and ReserveOne entered into a Mutual Termination Agreement (the "**Termination Agreement**") pursuant to which the parties agreed to mutually terminate the BCA, pursuant to Section 7.1(a) of the BCA (other than certain customary limited provisions that survive the termination pursuant to the terms of the BCA) effective June 12, 2026.

By virtue of the termination of the BCA, each of the Equity PIPE Subscription Agreements, the Convertible Notes Subscription Agreements and the Sponsor Support Agreement (each as defined in the BCA and together, the "**Subscription Agreements**") terminated in accordance with their respective terms.

**Securities Purchase Agreement**

On June 12, 2026, the Company entered into Securities Purchase Agreements (collectively, the "**Securities Purchase Agreements**") with MI7 Sponsor, LLC, a Delaware limited liability company and the sponsor of the Company (the "**Sponsor**"), ReserveOne, Pubco and certain investors (collectively, the "**Investors**") named therein. Pursuant to the Securities Purchase Agreements, upon the effectiveness of the Amendments (as defined below), among other things, the Sponsor has agreed to sell, and the Investors have agreed to purchase an aggregate of 4,279,279 Class A ordinary shares, par value $0.0001 per share, of the Company (the "**Class A Shares**,") issuable upon the conversion of the Sponsor's Class B ordinary shares, par value $0.0001 (the "**Class B Shares**"), which pursuant to the Securities Purchase Agreements, the Sponsor has agreed to convert to Class A Shares and which the parties have agreed to continue to treat as "Founder Shares" as described in the Securities Purchase Agreements. The Investors will purchase these Class A Shares for a price per share equal to $3.33 (such purchased shares, the "**Transferred Shares**") resulting in aggregate gross proceeds to the Sponsor of $14,250,000. Each of the Investors has deposited an amount equal to the purchase price for the Transferred Shares it agreed to purchase into an escrow account with funds to be released upon the closing of the transactions contemplated by the Securities Purchase Agreements (the "**Transaction**").

Contemporaneously with the execution of the Securities Purchase Agreements:

● the Company and ReserveOne entered into the Termination Agreement;

● the Company and the Investors entered into Joinder Agreements (the "**Transferred Shares Registration Rights Joinders**") to that certain Registration Rights Agreement, dated as of July 31, 2024, by and among the Company, the Sponsor and Cantor Fitzgerald & Co. (the "**Registration Rights Agreement** "), pursuant to which, among other things, (i) the Transferred Shares will be "Registrable Securities" as such term is defined in the Registration Rights Agreement; and (ii) upon the transfer of the Transferred Shares to the Investors, each Investor will join in, and agree to become a party to and be bound by and subject to, certain provisions of the Registration Rights Agreement with respect to the Transferred Shares; and

● the Company, the Sponsor and the Investors entered into Joinder Agreements (the "**Transferred Shares Letter Agreement Joinders**") to that certain Letter Agreement, dated as of July 31, 2024 (the "**Letter Agreement** "), pursuant to which, among other things, upon the transfer of the Transferred Shares to the Investors, each Investor will join in, and agree to become a party to and be bound by and subject to, the provisions set forth in Sections 1, 2, 6, 7, 11, and 13 through 20 of the Letter Agreement applicable to the Sponsor as such terms relate to the trans fer of the Transferred Shares.

The closings of the Transactions shall take place upon the effective date of certain contemplated amendments to the Company's Amended and Restated Memorandum and Articles of Association (the "**Articles**") (as discussed below), subject to certain closing conditions including, among others, that (i) the Termination Agreement continues to be in full force and effect and has not been rescinded, withdrawn, or otherwise become ineffective, and (ii) the termination of the Subscription Agreements continues to be in full force and effect and has not been rescinded, withdrawn, or otherwise become ineffective.

The Securities Purchase Agreements contain mutual releases by the Company, the Sponsor, ReserveOne and Pubco, on the one hand, and the Investors, on the other hand, for all claims known and unknown, arising out of or in connection with (i) the Subscription Agreements, (ii) the BCA, and (iii) the termination of any of the foregoing. If the transactions contemplated by the Securities Purchase Agreements have not closed on or before August 2, 2026, the Investors may terminate their respective Securities Purchase Agreements and receive a return of their funds held in escrow, in accordance with the terms of the Securities Purchase Agreements.

Contemporaneously with the execution and delivery of the Securities Purchase Agreements, ReserveOne, Pubco and the Company withdrew the Registration Statement on Form S-4 (Registration No. 333-279951) declared effective by the Securities and Exchange Commission (the "**SEC**") on May 13, 2026.

A portion of the net proceeds from the sale of the Transferred Shares is expected to be used by the Sponsor to make one or more loans to the Company up to an aggregate of $4,000,000 for purposes of paying "**Covered Expenses**" (as defined in the Securities Purchase Agreement), which consist of accrued expenses of the Company that are due and payable by the Company as of the closing of the Transaction.

**Shareholder Meeting**

The Company intends, as promptly as practicable after the execution of the Securities Purchase Agreements, to prepare and file with the SEC a proxy statement for the purpose of soliciting proxies from the Company's shareholders to approve, at an extraordinary general meeting of the Company's shareholders (the "**Shareholder Meeting**"), amendments to its Articles, to, among other things: (i) extend the date by which the Company must consummate an initial business combination by 12 months (from August 2, 2026 to August 2, 2027); (ii) permit the Company, following the effective date of the amendments after all redemptions pursuant to the exercise of redemption rights arising in connection with the amendments have been settled, to withdraw up to an aggregate amount of interest earned on the funds held in the Company's trust account in an amount equal to $0.10 for each Class A Share issued in the Company's initial public offering that is not redeemed and remains outstanding immediately following the effective date of the amendments, of which (a) $1,000,000 will be used to fund working capital and pay certain ordinary course expenses of the Company and (b) any amounts in excess of such $1,000,000 will be used to pay Covered Expenses; (iii) change the Company's legal name to Velos Acquisition I Corp.; (iv) remove Article 49.12 (the fairness opinion requirement) from the Articles in its entirety; and (v) such other modifications to the Articles as may be necessary to give effect to amendments (i) – (iv) (such amendments to the Articles, the "**Amendments**" and such proposals to be presented at the Shareholder Meeting, the "**Amendment Proposals**").

**Voting and Non-Redemption Agreements**

On June 12, 2026, the Company, the Sponsor, ReserveOne and Pubco entered into Voting Support and Non-Redemption Agreements (the "**Voting and Non-Redemption Agreements**") with certain investors (such investors entering the Voting and Non-Redemption Agreements, collectively, the "**Voting and Non-Redemption Shareholders**") pursuant to which the Voting and Non-Redemption Shareholders have agreed not to redeem up to an aggregate of approximately 16,000,000 Class A Shares in connection with the Amendments. Pursuant to the Voting and Non-Redemption Agreements, the Voting and Non-Redemption Shareholders have agreed to vote in favor of the Amendment Proposals at the Shareholder Meeting. The Voting and Non-Redemption Agreements provide that the Sponsor will transfer up to an aggregate of 8 million private placement warrants (the "**Private Placement Warrants**") held by the Sponsor to the Voting and Non-Redemption Shareholders in consideration for the Voting and Non-Redemption Shareholders' agreement to hold and not redeem their Class A Shares in connection with the Amendments.

Contemporaneously with the execution of the Voting and Non-Redemption Agreements:

● the Company and ReserveOne entered into the Termination Agreement;

● the Company and the Voting and Non-Redemption Shareholders entered into Joinder Agreements (the "**Private Placement Registration Rights Joinders**") to the Registration Rights Agreement, pursuant to which, among other things, (i) the transferred Private Placement Warrants will be "Registrable Securities" as such term is defined in the Registration Rights Agreement; and (ii) upon the transfer of the Private Placement Warrants to the Voting and Non-Redemption Shareholders, each Voting and Non-Redemption Shareholder will join in, and agree to become a party to and be bound by and subject to, the provisions of the Registration Rights Agreement; and

● the Company, the Sponsor and the Voting and Non-Redemption Shareholders entered into Joinder Agreements (the "**Private Placement Letter Agreement Joinders**") to the Letter Agreement, pursuant to which, among other things, upon the transfer of the Private Placement Warrants to the Voting and Non-Redemption Shareholders, each Voting and Non-Redemption Shareholder will join in, and agree to become a party to and be bound by and subject to, the provisions set forth in Section 7 of the Letter Agreement applicable to the Sponsor as such terms relate to the transfer of the Private Placement Warrants.

The Voting and Non-Redemption Agreements provide that as soon as practicable following the closing of the transactions contemplated by the Voting and Non-Redemption Agreements, the Company will prepare and file with the SEC a Registration Statement on Form S-1 (the "**Form S-1**") covering the resale of all Class A Shares purchased by the Voting and Non-Redemption Shareholders from Cantor Fitzgerald & Co., if any, for an offering to be made on a continuous basis pursuant to Rule 415 promulgated by the SEC pursuant to the Securities Act of 1933, as amended. The Company will use its commercially reasonable efforts to cause the Form S-1 to be declared effective by the SEC as promptly as possible after the filing thereof.

The Voting and Non-Redemption Agreements contain mutual releases by the Company, the Sponsor, ReserveOne and Pubco, on the one hand, and the Voting and Non-Redemption Shareholders, on the other hand, for all claims known and unknown, arising out of or in connection with the Equity PIPE Subscription Agreements and/or the Convertible Notes Subscription Agreements.

**Voting Agreements**

On June 12, 2026, the Company, the Sponsor, ReserveOne and Pubco entered into Voting Support Agreements (the "**Voting Agreements**") with certain unaffiliated third parties (collectively, the "**Voting Shareholders**") pursuant to which the Voting Shareholders agreed to vote in favor of the Amendment Proposals.

*The Termination Agreement and forms of the Securities Purchase Agreement, the Transferred Shares Registration Rights Joinder, the Transferred Shares Letter Agreement Joinder, the Voting and Non-Redemption Agreement, the Private Placement Registration Rights Joinder, the Private Placement Letter Agreement Joinder and Voting Agreement are filed as Exhibits 10.1, 10.2, 10.3, 10.4, 10.5, 10.6, 10.7 and 10.8 respectively, to this Current Report on Form 8-K, and the foregoing descriptions are qualified in their entirety by reference to the full text thereof, the terms of which are incorporated by reference herein.*

 

**Item 1.02. Termination of a Material Definitive Agreement.**

The information contained in Item 1.01 of this Current Report on Form 8-K with respect to the termination of the BCA, the Subscription Agreements and the Sponsor Support Agreement is incorporated by reference herein and made a part hereof.

 **Item 8.01. Other Events**

The information contained in Item 1.01 of this Current Report on Form 8-K is incorporated by reference herein and made a part hereof.

As previously announced in a definitive proxy statement filed with the SEC on May 13, 2026, the Company scheduled an extraordinary meeting of shareholders on June 15, 2026 for purposes of considering the BCA and related matters (the "**BCA Meeting**"). In addition, the Company announced in definitive additional materials on Schedule 14A filed with the SEC on June 10, 2026, a postponement of the BCA Meeting to Thursday June 18, 2026.

In connection with the termination of the BCA pursuant to the Termination Agreement as described above, the Company's board of directors (the "**Board**") has approved the cancellation of the BCA Meeting and will not be soliciting shareholder approval of the proposals set forth in the Company's previously filed definitive proxy statement.

Following the termination of the BCA pursuant to the Termination Agreement and the Company's contemporaneous entry into the Securities Purchase Agreements, the Transferred Shares Registration Rights Joinders, the Transferred Shares Letter Agreement Joinders, the Voting and Non-Redemption Agreements, the Private Placement Registration Rights Joinders, the Private Placement Letter Agreement Joinders and Voting Agreements, the Company intends to conduct the Shareholder Meeting described above to seek shareholder approval of the Amendments.

On June 12, 2026, the Company issued a press release announcing the cancellation of the BCA Meeting and related matters. A copy of that press release is attached hereto as Exhibit 99.1 and is incorporated herein by reference.

 **Item 9.01. Financial Statements and Exhibits.**

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(d) *Exhibits*

 

---

| | |
|:---|:---|
| Exhibit No. | Description |
| 10.1 | [Mutual Termination Agreement, dated as of June 12, 2026, by and between the Company and ReserveOne.](ea029455601ex10-1.htm) |
| 10.2 | [Form of Securities Purchase Agreement, dated of June 12, 2026, by and among the Company, ReserveOne, the Sponsor, Pubco and the Investors.](ea029455601ex10-2.htm) |
| 10.3 | [Form of Joinder Agreement to the Registration Rights Agreement (Transferred Shares), dated as of June 12, 2026, by and between the Company and the Investors.](ea029455601ex10-3.htm) |
| 10.4 | [Form of Joinder Agreement to the Letter Agreement (Transferred Shares), dated as of June 12, 2026, by and between the Company and the Investors.](ea029455601ex10-4.htm) |
| 10.5 | [Form of Voting Support and Non-Redemption Agreements, dated as of June 12, 2026, by and among, the Company, the Sponsor, ReserveOne, Pubco and the Voting and Non-Redemption Shareholders.](ea029455601ex10-5.htm) |
| 10.6 | [Form of Joinder Agreement to the Registration Rights Agreement (Private Placement Warrants), dated as of June 12, 2026, by and between the Company and the Voting and Non-Redemption Shareholders.](ea029455601ex10-6.htm) |
| 10.7 | [Form of Joinder Agreement to the Letter Agreement (Private Placement Warrants), dated as of June 12, 2026, by and between the Company and the Voting and Non-Redemption Shareholders.](ea029455601ex10-7.htm) |
| 10.8 | [Form of Voting Support Agreement, dated as of June 12, 2026, by and among the Company, the Sponsor, ReserveOne, Pubco and the Voting Shareholders.](ea029455601ex10-8.htm) |
| 99.1 | [Press Release dated June 12, 2026](ea029455601ex99-1.htm) |
| 104 | Cover Page Interactive Data File (embedded within the Inline XBRL document). |

---

<u>SIGNATURE</u>

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

---

| | | | |
|:---|:---|:---|:---|
|  | M3-Brigade Acquisition V Corp. | M3-Brigade Acquisition V Corp. | M3-Brigade Acquisition V Corp. |
| Date: June 12, 2026 | By: | /s/ Robert Rivas Collins | /s/ Robert Rivas Collins |
|  |  | Name: | Robert Rivas Collins |
|  |  | Title: | Chief Executive Officer |

---

## Exhibit 10.1

**Exhibit 10.1**

**MUTUAL TERMINATION AGREEMENT**

This MUTUAL TERMINATION AGREEMENT (this "***Agreement***") is made and entered into as of June 12, 2026 (the "***Effective Date***"), by and among M3-Brigade Acquisition V Corp., a Cayman Islands exempted company incorporated with limited liability ("***M3***"), and ReserveOne, Inc., a Delaware corporation (the "***Company***"). Capitalized terms used herein but not defined herein shall have the meanings ascribed to such terms in the BCA (as defined below).

**WHEREAS**, (i) M3, (ii) the Company, (iii) ReserveOne Holdings, Inc., a Delaware corporation and a wholly owned subsidiary of the Company, (iv) R1 SPAC Merger Sub, Inc., a Delaware corporation and a wholly owned subsidiary of Pubco, and (v) R1 Company Merger Sub, Inc., a Delaware corporation and a wholly owned subsidiary of Pubco have entered into that certain Business Combination Agreement, dated as of July 7, 2025 (the "***BCA***");

**WHEREAS**, Section 7.1(a) of the BCA provides that the BCA may be terminated by the mutual written consent of M3 and the Company; and

**WHEREAS**, the Boards of Directors of M3 and the Company have determined that it is in the best interests of their respective companies and their respective shareholders to terminate the BCA in accordance with the terms hereof.

**NOW, THEREFORE**, in consideration of the mutual covenants, representations, warranties and agreements contained herein, and intending to be legally bound hereby, the parties agree as follows:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;1. M3 and the Company hereby mutually agree to irrevocably terminate the BCA, effective as of the Effective Date, such agreement constituting the requisite mutual agreement and written consent required to terminate the BCA pursuant to Section 7.1(a) of the BCA and otherwise as may be required pursuant to applicable law.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;2. M3 and the Company mutually agree that the BCA shall forthwith become void (and there shall be no Liability or obligation on the part of the Parties and their respective Non-Party Affiliates) with the exception of (a) <u>Section 5.3(a)</u>, <u>Section 7.2</u>, <u>Article 8</u> and <u>Article 1</u> (to the extent related to the foregoing), and (b) the Confidentiality Agreement, which shall survive such termination and remain valid and binding obligations of the parties thereto in accordance with their respective terms.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;3. Each party hereby represents and warrants to the other party that (a) such party has full corporate power and authority to execute and deliver this Agreement, (b) the execution and delivery of this Agreement, the termination of the BCA and consummation of the other transactions contemplated hereby have been duly and validly approved by the board of directors of such party, (c) no other corporate proceedings on the part of such party are necessary to approve this Agreement or the termination of the BCA or the transactions contemplated thereby, and (d) this Agreement has been duly executed and delivered by such party, and assuming due authorization, execution and delivery of this Agreement by the other party, this Agreement is a valid and legally binding obligation, enforceable in accordance with its terms, except as enforceability may be limited by applicable bankruptcy, insolvency, fraudulent transfer, reorganization, moratorium and similar laws affecting the enforcement of rights of creditors or by general principles of equity.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;4. Neither this Agreement nor any of the rights, interests or obligations hereunder shall be assigned by any party (whether by operation of law or otherwise) without the prior written consent of the other party (which may be withheld by such other party in its sole discretion). Any purported assignment in contravention hereof shall be null and void. This Agreement (including the documents and instruments referred to herein) is not intended to confer upon any Person other than the parties hereto any rights or remedies hereunder, including the right to rely upon the representations and warranties set forth herein, provided that, the parties acknowledge that the termination of the BCA will result in the termination of the Equity PIPE Subscription Agreements and the Convertible Notes Subscription Agreements.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;5. Subject to Section 4 above, this Agreement will be binding upon, inure to the benefit of and be enforceable by M3, the Company and their respective successors and assigns. This Agreement (including the documents and instruments referred to herein) is not intended to confer upon any Person other than the parties hereto any rights or remedies hereunder, including the right to rely upon the representations and warranties set forth herein, provided that the parties acknowledge that the termination of the BCA will result in the termination of the Equity PIPE Subscription Agreements and the Convertible Notes Subscription Agreements.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;6. This Agreement and the Confidentiality Agreement contain the entire agreement between M3 and the Company with respect to the matters referenced herein and, except as specifically set forth herein, supersedes all prior arrangements or understandings with respect thereto.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;7. This Agreement shall be governed by, and construed in accordance with, the laws of the State of Delaware without regard to the conflict of law principles thereof.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;8. This Agreement may be executed in any number of counterparts, each of which shall be an original, but such counterparts together shall constitute one and the same agreement. This Agreement may be executed by electronic transmission signature and such signature shall constitute an original for all purposes.

[Signature page follows]

**IN WITNESS WHEREOF**, the parties hereto have caused this Agreement to be executed by their respective officers thereunto duly authorized as of the date first above written.

---

| | |
|:---|:---|
| **M3-BRIGADE ACQUISITION V CORP**. | **M3-BRIGADE ACQUISITION V CORP**. |
| By: | /s/ Robert Rivas Collins |
| Name: | Robert Rivas Collins |
| Title: | Chief Executive Officer |

---

[Signature Page to Mutual Termination Agreement]

---

| | |
|:---|:---|
| **RESERVEONE, INC.** | **RESERVEONE, INC.** |
| By: | /s/ Jaime Leverton |
| Name: | Jaime Leverton |
| Title: | Chief Executive Officer |

---

[Signature Page to Mutual Termination Agreement]

## Exhibit 10.2

**Exhibit 10.2**

**SECURITIES PURCHASE AGREEMENT**

THIS SECURITIES PURCHASE AGREEMENT (this "**Agreement**"), dated as of June 12, 2026, is made and entered into by and among the undersigned investor ("**Buyer**"), MI7 Sponsor, LLC, a Delaware limited liability company ("**Seller**"), ReserveOne, Inc., a Delaware corporation ("**ReserveOne**"), ReserveOne Holdings, Inc., a Delaware corporation ("**R-1 Holdings**"), and M3-Brigade Acquisition V Corp., a Cayman Islands exempted company (the "**SPAC**").

Unless otherwise stated herein, capitalized terms used in this Agreement shall have the meanings ascribed to them in the prospectus relating to the registration statement on Form S-1 of M3-Brigade Acquisition V Corp. first filed with the U.S. Securities and Exchange Commission (the "**SEC**") on June 5, 2024 (Registration No. 333-279951), as amended and as declared effective on July 31, 2024, and as may be supplemented or post-effectively amended from time to time (the "**Registration Statement**").

**RECITALS**

**WHEREAS**, the SPAC was incorporated on March 12, 2024, and consummated an initial public offering of its units on August 2, 2024, generating gross proceeds of $287,500,000 (the "**IPO**");

**WHEREAS**, the Class A ordinary shares, par value $0.0001 per share, of the SPAC ("**Class A Shares**"), and associated warrants to purchase Class A Shares ("**Listed Warrants**"), and units of the SPAC are listed on The Nasdaq Stock Market LLC ("**Nasdaq**") under the trading symbols "MBAV", "MBAVW" and "MBAVU", respectively;

**WHEREAS**, Seller is the sponsor of the SPAC, and as of the date hereof, owns 7,187,500 Class B ordinary shares, par value $0.0001 per share, of the SPAC ("**Class B Shares**");

**WHEREAS**, Seller, as of the date hereof, holds 8,337,500 warrants to purchase 8,337,500 Class A Shares at a purchase price of $11.50 per share (the "**Private Placement Warrants**");

**WHEREAS**, the SPAC, ReserveOne, R-1 Holdings and certain other parties entered into a business combination agreement dated July 7, 2025 (the "**Business Combination Agreement**");

**WHEREAS**, the SPAC and Cantor Fitzgerald & Co., as representative of the underwriters thereto, are parties to that certain Underwriting Agreement, dated as of July 31, 2024 (the "**Underwriting Agreement**");

**WHEREAS**, the SPAC and Continental Stock Transfer & Trust Co., as trustee (the "**Trustee**"), are parties to that certain Investment Management Trust Agreement, dated as of July 31, 2024 (the "**Trust Agreement**");

**WHEREAS**, the SPAC intends to make certain amendments to its Amended and Restated Memorandum and Articles of Association (the "**Articles**"), including to (i) change the SPAC name to Velos Acquisition I Corp.; (ii) delete the fairness opinion requirement pursuant to Section 49.12 of the Articles; (iii) extend the date by which the SPAC must consummate an initial business combination by 12 months (to August 2, 2027); (iv) permit withdrawals of a certain amount of interest from the SPAC's trust account (the "**Trust Account**") as set forth in such amendments to the Articles; and (v) such other modifications to the Articles as may be necessary to give effect to amendments (i) – (iv) (such amendments to the Articles, the "**Amendments**");

**WHEREAS**, Seller, the SPAC, ReserveOne, and R-1 Holdings are entering into voting support and non-redemption agreements with certain SPAC shareholders, pursuant to which, among other things, such SPAC shareholders will agree to (i) vote all Class A Shares owned by such individual SPAC shareholder in favor of the Amendments, (ii) not exercise any right to redeem their Class A Shares in connection with the Amendments, and (iii) reverse and revoke any prior redemption elections made with respect to their Class A Shares in connection with the Amendments (collectively, the "**Voting Support and Non-Redemption Agreements**");

**WHEREAS**, Seller wishes to sell, assign, transfer, convey and deliver, and Buyer wishes to purchase from Seller, the number of Class A Shares issuable upon conversion of Seller's Class B Shares set forth on <u>Schedule A</u> hereto (the "**Transferred Shares**"), subject to the terms and conditions set forth herein;

**WHEREAS**, Seller, the SPAC, ReserveOne and R-1 Holdings are entering into similar agreements with certain other investors (the "**Other Agreements**"); and

**WHEREAS**, in connection with this Agreement, certain of the parties hereto are, as of even date herewith, entering into the following additional agreements (the "**Additional Agreements**"):

● Mutual Termination Agreement, by and between the SPAC and ReserveOne (the "**BCA Termination Agreement** ");

● Joinder Agreement by and between the SPAC and Buyer (the "**Registration Rights Joinder**") in connection with that certain Registration Rights Agreement, dated as of July 31, 2024, by and among the SPAC, the Seller (as assignee of M3-Brigade Sponsor V LLC) and Cantor Fitzgerald & Co. (the "**Registration Rights Agreement** ");

● Joinder Agreement, by and between the SPAC and Buyer (the "**Letter Agreement Joinder**") in connection with certain provisions of that certain Letter Agreement, dated as of July 31, 2024, by and among the SPAC, the Seller, and the other parties thereto (the "**Letter Agreement** "); and

● Stock Power and Assignment, by and among Buyer, the Seller, and the SPAC (the "**Assignment Agreement** ").

**NOW, THEREFORE**, in consideration of the mutual covenants and agreements hereinafter set forth and for other good and valuable consideration, the receipt and sufficiency of which are hereby acknowledged, the parties hereto, intending to be legally bound by the terms hereof, agree as follows:

**Article I.**

**PURCHASE AND SALE**

**Section 1.01 Purchase and Sale. Subject to the terms and conditions set forth herein, Seller shall sell to Buyer, and Buyer shall purchase from Seller, all of Seller's right, title, and interest in and to the Transferred Shares for the consideration specified in Section 1.02. The Transferred Shares shall be free and clear of any mortgage, pledge, lien, charge, security interest, claim, or other encumbrance ("Encumbrance"), other than any encumbrances that may exist as a result of applicable securities laws, the Letter Agreement, the Registration Rights Agreement, the Underwriting Agreement, and the Articles and other governing documents of the SPAC, as amended by the Amendments (collectively, the "Permitted Encumbrances").**

**Section 1.02 Purchase Price. The purchase price for the Transferred Shares is set forth on <u>Schedule A</u> hereto (the "Purchase Price"). Concurrently with the execution and delivery of this Agreement, Buyer shall pay the Purchase Price in cash by wire transfer of immediately available funds into an escrow account (the "Escrow Account") to be held in escrow by an entity that offers commercial escrow services, pursuant to an Escrow Agreement which shall include the terms and conditions set forth in <u>Exhibit I</u> hereto (the "Escrow Agreement").**

**Section 1.03 Termination of Business Combination Agreement. Upon (i) the exchange of executed signature pages of (a) this Agreement, (b) each of the Registration Rights Joinder and the Letter Agreement Joinder (collectively, the "Joinder Agreements") and (c) the Assignment Agreement, by the relevant parties hereto; and (ii) the funding of the Escrow Account, Seller shall deliver to Buyer a copy of the BCA Termination Agreement. Such BCA Termination Agreement shall be unconditional and irrevocable, and shall not be rescinded, withdrawn, or otherwise become ineffective regardless of whether the Amendments become effective, whether the Closing (as defined herein) occurs, or whether the funds in the Escrow Account are released to Buyer pursuant to the Escrow Agreement. In addition, the parties acknowledge and agree that (A) to the extent applicable, if the parties are a party to any Subscription Agreements entered into as of July 7, 2025, in connection with the Business Combination Agreement, by and among ReserveOne, R-1 Holdings, the SPAC and the parties thereto (the "Subscription Agreements"), such Subscription Agreements automatically terminate pursuant to the terms of the Subscription Agreements upon termination of the Business Combination Agreement in accordance with the terms of the Business Combination Agreement, and (B) the BCA Termination Agreement is intended to, and shall, constitute a termination of the Business Combination Agreement in accordance with the terms of the Business Combination Agreement for purposes of the termination sections of the Subscription Agreements. For the avoidance of doubt and as a separate and independent matter, as of the date hereof, the Subscription Agreements are hereby expressly terminated in their entirety and shall be of no further force or effect, with no further liability or obligation of any party thereunder, except for any provisions thereof that by their terms survive termination of the Subscription Agreements.**

**Section 1.04 Closing. The closing of the transactions contemplated by this Agreement (the "Closing") shall take place upon the effective date of the Amendments, subject to satisfaction of the other conditions set forth herein (the "Closing Date"). At the Closing:**

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(a) the Purchase Price shall be paid from the Escrow Account in cash by wire transfer in immediately available funds to an account or accounts designated by Seller; and

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b) the SPAC shall deliver a corresponding irrevocable instruction to the SPAC's transfer agent or registered office (as the case may be), to update its records accordingly, and, if requested or required by such transfer agent or registered office (as the case may be), the SPAC will cause its counsel to issue an opinion to such transfer agent that the sale of the Transferred Shares may be made without registration under the Securities Act of 1933, as amended (the "**Securities Act**").

The consummation of the transactions contemplated by this Agreement shall be deemed to occur at 12:01 a.m. E.T. on the Closing Date. If the Closing has not occurred on or before August 2, 2026 (the "**Outside Date**"), this Agreement may be terminated by Buyer by written notice to Seller, in which event the funds held in the Escrow Account shall be promptly returned to Buyer in accordance with the Escrow Agreement, but in no event more than two (2) business days; <u>provided</u>, however, that the BCA Termination Agreement, the termination of the Subscription Agreements pursuant to <u>Section 1.03</u>, and the mutual releases set forth in <u>Article IV</u> shall survive any such termination of this Agreement and remain in full force and effect.

**Section 1.05 Buyer's Acknowledgment. Buyer acknowledges that, upon the effectiveness of the Amendments, Seller will cause all Class B Shares to be converted to Class A Shares and such Class A Shares will continue to be treated as Founder Shares for all purposes, including, without limitation, under the SPAC's organizational documents, the Letter Agreement, and the Registration Rights Agreement.**

**Section 1.06 Buyer's Closing Conditions. The obligations of Buyer hereunder in connection with the Closing are subject to the satisfaction (or Buyer's waiver of one or more at the Buyer's sole discretion) of the following conditions:**

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(a) effectiveness of the Amendments;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b) the BCA Termination Agreement shall continue to be in full force and effect and shall not have been rescinded, withdrawn, or otherwise become ineffective; and

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(c) the termination of the Subscription Agreements shall continue to be in full force and effect and shall not have been rescinded, withdrawn, or otherwise become ineffective.

**Section 1.07 Seller's Closing Conditions. The respective obligations of Seller hereunder in connection with the Closing are subject to the satisfaction (or Seller's waiver of one or more) of the following conditions:**

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(a) effectiveness of the Amendments; and

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b) payment of the Purchase Price from the Escrow Account in cash by wire transfer in immediately available funds to an account or accounts designated by Seller.

**Section 1.08 Adjustments. If, between the date hereof and the Closing, the outstanding Class A Shares or Class B Shares of the SPAC are changed into a different number or kind of shares or securities by reason of any stock split, reverse stock split, recapitalization, reclassification, combination, exchange of shares, or other similar transaction, the number of Transferred Shares to be delivered at Closing and the Purchase Price per share shall each be appropriately and proportionately adjusted to give Buyer and Seller the same economic effect as contemplated by this Agreement immediately prior to such transaction.**

**Article II.**

**REPRESENTATIONS AND WARRANTIES OF SELLER**

Seller and the SPAC hereby represent and warrant to Buyer that each of the representations and warranties contained in this <u>Article II</u> is true, correct, and complete, in all material respects, as of the date hereof and as of the Closing Date, except for representations and warranties made as of a specified date. For purposes of this Article II, "Seller's knowledge," "knowledge of Seller," and any similar phrases (or any analogous phrases referencing the SPAC) shall mean the actual or constructive knowledge of any director or executive officer of Seller (or the SPAC, as the case may be), as if such executive officers and directors shall have made diligent inquiry of the matters presented, or a reasonably prudent individual operating in the capacity of an executive officer or director could be expected to discover or otherwise become aware of such a fact or matter.

**Section 2.01 Organization and Authority; Enforceability. Each of Seller and the SPAC is an entity duly incorporated or organized, validly existing, and in good standing with its state or jurisdiction of incorporation or organization. Seller has full power and authority to enter into this Agreement, the applicable Additional Agreements, and the documents to be delivered hereunder, to carry out its obligations hereunder, and to consummate the transactions contemplated hereby. The execution, delivery, and performance by the SPAC and Seller of this Agreement and the documents to be delivered hereunder and the consummation of the transactions to which it is a party, which are contemplated hereby and thereby, have been duly authorized by all requisite action on its part (or its governing body, if applicable). This Agreement and the documents to be delivered hereunder have been duly executed and delivered by the SPAC and Seller, and, assuming due authorization, execution, and delivery by Buyer, this Agreement and the documents to be delivered hereunder constitute legal, valid, and binding obligations of the SPAC and Seller, enforceable against the SPAC and Seller in accordance with their respective terms.**

**Section 2.02 SPAC Liabilities.**

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(a) As of the Closing, the SPAC will have no accrued and unpaid liabilities (including all known, estimated, contingent or deferred liabilities of the SPAC, regardless of whether set forth on the SPAC's balance sheet) except for (i) the accrued expenses that are due and payable as of the Closing Date (the "**Covered Expenses**"), which will be paid promptly after the Closing Date, (ii) the deferred liabilities set forth on <u>Schedule B</u> hereto (collectively, the "**Deferred Liabilities**") that are due and payable upon the consummation of the SPAC's business combination, and (iii) Ordinary Course Expenses (as defined herein) which will be payable in the ordinary course.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b) As of the Closing, except for Covered Expenses, Deferred Liabilities or Ordinary Course Expenses, (i) there will be no unpaid compensation owed by the SPAC or Seller to any officers, directors or advisors of the SPAC, and (ii) the SPAC has no other tax liability or obligations outstanding, other than any accrued franchise or similar taxes owed to the applicable authorities in the Cayman Islands, which have not yet become due and payable. As of the Closing Date, the Covered Expenses, the Deferred Liabilities and Ordinary Course Expenses will constitute all liabilities of the SPAC (whether accrued, disputed, contingent, or otherwise, and whether due or to become due), and represent all accrued liabilities known to Seller. Except for the (x) the Underwriting Agreement, (y) the Engagement Letter dated June 11, 2025, between the SPAC and Lincoln Financial LLC (the "**Lincoln Engagement Letter**"), and (z) the Sponsor Notes (as defined on Schedule B attached hereto), Seller has no agreement with any third party to pay, or cause the SPAC to pay, any fee contingent on consummation of a business combination. Notwithstanding the foregoing, expenses incurred by the SPAC in the ordinary course, including without limitation with respect to legal, accounting, printing, insurance, trust and stock transfer services, not in excess of $1,000,000 in the aggregate (the "**Ordinary Course Expenses**") shall not cause the representations and warranties contained in this <u>Section 2.02</u> to be deemed to be incorrect in any material respect.

**Section 2.03 Legal Proceedings. There is no claim, action, suit, proceeding, or governmental investigation or exchange inquiry (collectively, "Action") against the SPAC or Seller of any nature pending or, to Seller's knowledge, threatened against the SPAC or Seller that challenges or seeks to prevent, enjoin, or otherwise delay or have an adverse effect on the transactions contemplated by this Agreement, or seeks any monetary compensation from the SPAC. No event has occurred or circumstances exist, that would reasonably be expected to give rise to, or serve as a basis for, any such Action. Seller has no knowledge of any facts or circumstances that are likely to give rise to litigation against the SPAC and/or Seller.**

**Section 2.04 No Conflicts. The execution, delivery, and performance by Seller of this Agreement and the documents to be delivered hereunder, including the Additional Agreements, and the consummation of the transactions contemplated hereby, do not and will not: (a) violate or conflict with or constitute a default under any organizational documents of the SPAC or Seller, including any operating agreement of Seller; (b) violate or conflict with any rule of the statute, law, Nasdaq, the SEC or any other ordinance, rule, or regulation applicable to the SPAC or Seller; (c) violate or conflict with or result in a violation or breach of any provision of any material agreement to which Seller or the SPAC is a party, or (d) result in the creation or imposition of any Encumbrance on the Transferred Shares, other than the Permitted Encumbrances. Notwithstanding the foregoing, immaterial violations or conflicts which do not result in financial liability to the SPAC or adversely affect the validity of the consummation of the transactions contemplated hereby shall be deemed not to cause the representations and warranties contained solely in <u>Section 2.04</u> to be untrue in any material respect.**

**Section 2.05 Consents and Approvals. Seller has obtained all consents, approvals, waivers, or authorizations required to be obtained by it from any Person or entity (including any governmental authority) in connection with the execution, delivery, and performance by Seller of this Agreement, the Additional Agreements and the consummation of the transactions contemplated hereby, including approval by the SPAC's board of directors. For purposes of this Agreement, the term "Person" means an individual, corporation, partnership, joint venture, limited liability company, governmental authority, unincorporated organization, trust, association, or other entity.**

**Section 2.06 Capitalization of SPAC; Ownership; Trust Account Balance.**

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(a) As of the date hereof, (i) the authorized share capital of the SPAC consists of 200,000,000 Class A Shares, 20,000,000 Class B Shares and 1,000,000 preference shares of a par value of US$0.0001 each, (ii) 28,750,000 Class A Shares are issued and outstanding and 7,187,500 Class B Shares are issued and outstanding, and (iii) there are 8,337,500 Private Placement Warrants issued and outstanding and 14,375,000 Listed Warrants issued and outstanding. The recitals hereto set forth a true and correct listing of Class B Shares and Private Placement Warrants owned by Seller. Except as set forth in this <u>Section 2.06</u>, or as disclosed in SPAC SEC Reports (as defined herein), there are no other equity securities of the SPAC issued and outstanding, no preemptive or other outstanding rights, subscriptions, options, warrants, equity appreciation rights, redemption rights, repurchase rights, convertible, exercisable, or exchangeable into membership interests or (other than the Registration Rights Agreement) other agreements, arrangements or commitments of any character relating to the equity interests in of the SPAC or any other securities or obligations convertible or exchangeable into or exercisable for, or giving any Person a right to subscribe for or acquire, any equity interest in the SPAC. Except as disclosed in the SPAC SEC Reports, the SPAC does not have any outstanding bonds, debentures, notes or other obligations that grant to its holder voting rights in the SPAC on any matter or that are convertible or exchangeable into or exercisable for securities that grant to the holder of such converted or exchanged security voting rights in the SPAC on any matter (whether before or after the initial business combination). Except for this Agreement, the Other Agreements, and the Voting Support and Non-Redemption Agreements, the SPAC has no other outstanding contractual obligations related to its equity interests, including any voting agreement, voting trust, or similar arrangement, other than as disclosed in the SPAC SEC Reports. Seller is responsible for any and all past, present or future obligations related to its ownership through the Closing Date of such interests in the SPAC (for example individual or entity regulatory filings, taxes, etc.).

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b) As of May 20, 2026, the SPAC had an amount in cash in the Trust Account of at least $311,083,518.90. The funds held in the Trust Account are (i) held in an interest-bearing demand deposit account, United States treasury securities or money market funds comprised of United States treasury securities and (ii) held in trust pursuant to the Trust Agreement.

**Section 2.07 Transferred Shares.**

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(a) At the Closing, the Transferred Shares will be duly authorized, fully paid, validly issued, non-assessable, were not issued in violation of the organizational documents of the SPAC or Seller, including, for the avoidance of doubt, the Amendments, or any other agreement, arrangement, or commitment to which Seller or the SPAC is a party or by which their respective assets are bound, were issued in compliance with applicable securities laws or exemptions therefrom and are not subject to or in violation of any preemptive or similar rights of any Person.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b) Seller is the sole legal, record, and equitable owner of the Class B Shares that will be converted into the Transferred Shares, free and clear of all Encumbrances except any Permitted Encumbrances. Upon the sale of the Transferred Shares contemplated herein, Buyer will receive good and valid legal title to, and full beneficial ownership of, the Transferred Shares, free and clear of all Encumbrances whatsoever except any Permitted Encumbrances.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(c) Other than the Articles (including the Amendments) and other organizational documents of Seller and the SPAC, and as disclosed in the SPAC SEC Reports, this Agreement, the Other Agreements, and the Voting Support and Non-Redemption Agreements, there are no voting trusts, proxies, or other agreements or understandings in effect with respect to the voting, redemption or transfer of any of the Transferred Shares.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(d) The SPAC shall register the resale of the Transferred Shares under the Securities Act pursuant to the terms and conditions the Registration Rights Agreement.

**Section 2.08 Listing; SEC Reports; Material Events.**

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(a) The Class A Shares, Listed Warrants and the SPAC's units are listed on Nasdaq. There is no Action pending or threatened against the SPAC by Nasdaq with respect to any intention by such entity to prohibit or terminate the listing such securities.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b) The SPAC has filed or furnished, as applicable, all material registration statements, forms, reports and other documents required to be filed or furnished by the SPAC with the SEC since completion of its IPO. All such registration statements, forms, reports and other documents (including all exhibits thereto) are referred to herein as the "**SPAC SEC Reports**." The SPAC SEC Reports (i) were filed or furnished, as applicable, on a timely basis (including following any extensions of time for filing provided by Rule 12b-25 promulgated under the Exchange Act of 1934, as amended (the "**Exchange Act**")), (ii) as of their respective dates or, if amended and filed no later than five (5) business days prior to the date of this Agreement, as of the date of the last such amendment, complied, or will comply as of such date, as to form in all material respects with the applicable requirements of the Securities Act, and the Exchange Act, as the case may be, and the rules and regulations of the SEC thereunder applicable to such SPAC SEC Reports and (iii) including any financial statements or schedules included or incorporated by reference therein, did not or will not, as of their respective dates, or, if amended and filed no later than five (5) business days prior to the date of this Agreement, as of the last such amendment, contain any untrue statement of a material fact or omit to state a material fact required to be stated in such SPAC SEC Reports or necessary in order to make the statements in such SPAC SEC Reports, in the light of the circumstances under which they were made, not misleading. The audited financial statements and unaudited interim financial statements (including, in each case, the notes and schedules thereto) included in the SPAC SEC Reports complied as to form in all material respects with the published rules and regulations of the SEC with respect thereto, were prepared in accordance with GAAP applied on a consistent basis during the periods involved (except as may be indicated therein or in the notes thereto) and fairly present (subject, in the case of the unaudited interim financial statements included therein, to normal year-end adjustments and the absence of complete footnotes as permitted by the requirements of the SEC Quarterly Report on Form 10-Q) in all material respects the financial position of the SPAC as of the respective dates thereof and the results of its operations and cash flows for the respective periods then ended. No executive officer of the SPAC has failed to make the certifications required of him or her under Section 302 or 906 of the Sarbanes-Oxley Act with respect to any SPAC SEC Reports.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(c) No material events affecting the SPAC or the Transferred Shares (i) which are of a nature that would require public disclosure under applicable SEC rules or guidance, or (ii) resulting from any action or deliberate inaction by Seller or the SPAC, have occurred between December 31, 2025 and the execution of this Agreement, other than those events disclosed by the SPAC in SPAC SEC Reports.

**Section 2.09 Brokers. No broker, finder, or investment banker is entitled to any brokerage, finder's, or other fee or commission in connection with the transactions contemplated by this Agreement based upon arrangements made by or on behalf of Seller or the SPAC.**

**Section 2.10 Taxes. (a) All material tax returns (including information returns) required to be filed on or before the Closing Date by Seller and the SPAC have been timely filed, (b) all such tax returns are true, complete and correct in all material respects, (c) all taxes due and owing by Seller or the SPAC (whether or not shown on any tax return) have been timely paid, (d) all deficiencies asserted, or assessments made, against Seller and the SPAC as a result of any examinations by any taxing authority have been fully paid, (e) there are no pending or threatened Actions by any taxing authority of which the SPAC or Seller has knowledge, and (f) Seller represents that there are sufficient monies in the Trust Account to satisfy and current and future tax obligations. The SPAC is treated as a "foreign corporation" for U.S. federal income tax purposes and has not filed any U.S. entity tax classification elections.**

**Section 2.11 Trust Waivers. As of Closing, the SPAC will not have any outstanding Material Contracts (as defined herein), agreements, binding arrangements, bonds, notes, indentures, mortgages, debt instruments, purchase order, licenses leases and other instruments or obligations of any kind (including any amendments and other modifications thereto) with any vendors, service providers, prospective target businesses or other entities with which the SPAC does business (except its independent registered public accounting firm) which do not include a waiver by such counterparties of any right, title, interest or claim of any kind in or to any monies held in the Trust Account.**

**Section 2.12 Material Contracts. Each contract to which Seller and/or the SPAC is a party or by which any of their respective assets or properties are bound or subject to that are material to the business, assets, liabilities, financial condition, results of operations or prospects of Seller taken as a whole (each a "Material Contract" and collectively, the "Material Contracts") has either been filed or furnished in a SPAC SEC Report or provided to Buyer, other than agreements that will terminate on or prior to the Closing or ordinary course services agreements or arrangements, including without limitation for legal, accounting, printing, insurance trust and stock transfer services. Neither the Seller nor any other party thereto, is in breach or default under, or has provided or received any written notice of any intention to terminate, any Material Contract.**

**Section 2.13 Related Parties. The SPAC is not a party to any contract or arrangement with any related party or other Affiliate (as defined herein), other than (a) the Letter Agreement, (b) the Sponsor Notes (as defined on Schedule B attached hereto) and (c) any other agreements incidental to the IPO of the SPAC for which true and correct copies have been filed or furnished in a SPAC SEC Report. As of the Closing Date (after giving effect to the Closing and the transactions contemplated thereby), the SPAC shall have no outstanding accounts payable or debt obligations to Seller other than the Sponsor Notes. For the purposes of this Agreement, "Affiliate" or "Affiliates" of a Person means any other Person that directly or indirectly, through one or more intermediaries, controls, is controlled by, or is under common control with, such Person. The term "control" (including the terms "controlled by" and "under common control with") means the possession, directly or indirectly, of the power to direct or cause the direction of the management and policies of a Person, whether through the ownership of voting securities, by contract or otherwise.**

**Section 2.14 Books and Records. All Material Contracts, documents, financial statements, accounts, books and ledgers of the SPAC have been properly and accurately kept and completed in accordance in all material respects with applicable accounting standards, and there are no inaccuracies or discrepancies of any kind contained or reflected therein that, individually or in the aggregate, would reasonably be expected to be material to the SPAC. Neither Seller nor the SPAC has received any written or oral allegation, assertion or claim with respect to accounting, internal accounting controls, auditing practices, procedures, methodologies or methods of the SPAC or Seller, or unlawful accounting or auditing matters with respect to the SPAC or Seller.**

**Section 2.15 Accuracy and Completeness of Representations and Warranties. The representations and warranties of Seller contained in this Article II and elsewhere in this Agreement or in any other document or agreement executed and delivered by Seller in connection with the transactions contemplated hereby (including all Exhibits and Schedules hereto or thereto), are true and correct in all material respects and do not contain any untrue statement of a material fact or omit to state any material fact necessary to make the statements and information contained therein not misleading.**

**Section 2.16 No General Solicitation. Neither the SPAC nor, to the SPAC's knowledge, the Seller or any person acting on behalf of the SPAC or the Seller have, directly or indirectly, offered or sold any of the Transferred Shares or solicited any offers to buy any Transferred Shares, under any circumstances that would require registration under the Securities Act of the offer and sale of the Transferred Shares, including by any form of general solicitation or general advertising.**

**Article III.**

**REPRESENTATIONS AND WARRANTIES OF BUYER**

Buyer represents and warrants to Seller that the statements contained in this Article III are true, complete and correct in all material respects as of the date hereof and as of the Closing Date, except for representations and warranties made as of a specified date. For purposes of this Article III, "Buyer's knowledge," "knowledge of Buyer" and any similar phrases shall mean the actual or constructive knowledge of any director or officer of Buyer, as if such officers and directors shall have made diligent inquiry of the matters presented, or a reasonably prudent individual operating in the capacity of an officer or director could be expected to discover or otherwise become aware of such a fact or matter.

**Section 3.01 Organization and Authority of Buyer; Enforceability. Buyer is duly organized, validly existing, and in good standing with the state of its formation. Buyer has full power and authority to enter into this Agreement, the applicable Additional Agreements, and the documents to be delivered hereunder, to carry out its obligations hereunder, and to consummate the transactions contemplated hereby. The execution, delivery, and performance by Buyer of this Agreement and the documents to be delivered hereunder and the consummation of the transactions contemplated hereby have been duly authorized by all requisite action on the part of Buyer. This Agreement and the documents to be delivered hereunder have been duly executed and delivered by Buyer, and, assuming due authorization, execution, and delivery by Seller and the SPAC, this Agreement and the documents to be delivered hereunder constitute legal, valid, and binding obligations of Buyer enforceable against Buyer in accordance with their respective terms.**

**Section 3.02 No Conflicts; Consents. The execution, delivery, and performance by Buyer of this Agreement and the documents to be delivered hereunder, and the consummation of the transactions contemplated hereby, do not and will not: (a) violate or conflict with the organizational documents of Buyer; or (b) violate or conflict with any judgment, order, decree, statute, law, ordinance, rule, or regulation applicable to Buyer. No consent, approval, waiver, or authorization is required to be obtained by Buyer from any Person or entity (including any governmental authority) in connection with the execution, delivery, and performance by Buyer of this Agreement and the consummation of the transactions contemplated hereby.**

**Section 3.03 Investment Purpose. Buyer is acquiring the Transferred Shares solely for its own account for investment purposes and not with a view to, or for offer or sale in connection with, any distribution thereof. Buyer acknowledges that the Transferred Shares are not registered under the Securities Act, or registered under any state securities laws, and that the Transferred Shares may not be transferred or sold except pursuant to the registration provisions of the Securities Act, or pursuant to an applicable exemption therefrom and subject to state securities laws and regulations, as applicable.**

**Section 3.04 Accredited Investor. The Buyer hereby represents and warrants that it is an "accredited investor" as that term is defined in Rule 501(a) of Regulation D under the Securities Act. The Buyer has such knowledge and experience in financial and business matters that it is capable of evaluating the merits and risks of an investment in the securities offered under this Agreement, is making the investment for its own account (or for one or more accounts with respect to which it exercises sole investment discretion) and for investment purposes only and not with a view to distribution, is able to bear the economic risk of such investment, and can afford a complete loss of such investment.**

**Section 3.05 Brokers. No broker, finder, or investment banker is entitled to any brokerage, finder's, or other fee or commission in connection with the transactions contemplated by this Agreement based upon arrangements made by or on behalf of Buyer.**

**Section 3.06 Legal Proceedings. There is no Action of any nature pending or, to Buyer's knowledge, threatened against or by Buyer that challenges or seeks to prevent, enjoin, or otherwise delay the transactions contemplated by this Agreement. No event has occurred, or circumstances exist that may give rise to, or serve as a basis for, any such Action.**

**Section 3.07 Accuracy and Completeness of Representations and Warranties. The representations and warranties of Buyer contained in this Article III and elsewhere in this Agreement or in any other document or agreement executed and delivered by Buyer in connection with the transactions contemplated hereby (including all Exhibits and Schedules hereto or thereto), are true and correct in all material respects and do not contain any untrue statement of a material fact or omit to state any material fact necessary to make the statements and information contained therein not misleading.**

**Article IV.**

**RELEASES**

**Section 4.01 Release.**

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(a) Each of the SPAC, Seller, ReserveOne and R-1 Holdings, generally releases and discharges each of Buyer and its predecessors, successors (by merger or otherwise), parents, subsidiaries, Affiliates and assigns, together with each and every of their respective present, past and future officers, directors, shareholders, employees, representatives and agents and the family members, heirs and executors of same (collectively referred to herein as the "**Buyer Parties**") from any and all claims, actions, causes of action, demands, liens, agreements, contracts, covenants, actions, suits, causes of action, obligations, promises, controversies, complaints, debts, dues, costs, expenses, damages, judgments, orders and liabilities, of whatever kind or nature, direct or indirect, in law, equity or otherwise, whether known or unknown ("**Claims**"), that each of the SPAC, Seller, ReserveOne and R-1 Holdings ever had or now has against Buyer or any other member of the Buyer Parties arising out of or in connection with the (i) Subscription Agreements, (ii) the Business Combination Agreement, and (iii) the termination of any of the foregoing, including, without limitation, any and all Claims for attorneys' fees and costs with respect to the released Claims; <u>provided</u> that the foregoing is not intended to and shall not have the effect of limiting the ability of the SPAC, Seller, ReserveOne and R-1 Holdings to enforce this Agreement.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b) Buyer generally releases and discharges each of the SPAC, Seller, ReserveOne and R-1 Holdings and each of their predecessors, successors (by merger or otherwise), parents, subsidiaries, Affiliates and assigns, together with each and every of their respective present, past and future officers, directors, shareholders, employees, representatives and agents and the family members, heirs and executors of same (collectively referred to herein as the "**Seller Parties**") from any and all Claims that Buyer ever had or now has against each of the SPAC, Seller, ReserveOne and R-1 Holdings or any other member of the Seller Parties arising out of or in connection with the (i) Subscription Agreements, (ii) the Business Combination Agreement, and (iii) the termination of any of the foregoing, including, without limitation, any and all Claims for attorneys' fees and costs with respect to the released Claims; <u>provided</u> that the foregoing is not intended to and shall not have the effect of limiting the ability of Buyer to enforce this Agreement.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(c) Each party represents and warrants that it has not heretofore transferred or assigned, or purported to transfer or assign, to any person, firm, or corporation any Claims, Actions, liabilities or indemnities herein released. Each party further represents and warrants that neither it nor any assignee has filed any lawsuit against any other party.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(d) The parties each acknowledge that they may discover facts in addition to or different from those that they now know or believe to be true with respect to the matters released herein, but that it is the express intention of the parties, except as necessary to enforce this Agreement, to fully, finally and forever settle and release any and all Claims released hereby, known or unknown, suspected or unsuspected, which now exist, and without regard to the subsequent discovery or existence of such additional or different facts. In furtherance of this intention, the parties each expressly waive any and all provisions, rights and benefits of California Civil Code Section 1542, which provides:

A GENERAL RELEASE DOES NOT EXTEND TO CLAIMS WHICH THE CREDITOR DOES NOT KNOW OR SUSPECT TO EXIST IN HIS OR HER FAVOR AT THE TIME OF EXECUTING THE RELEASE, WHICH IF KNOWN BY HIM OR HER MUST HAVE MATERIALLY AFFECTED HIS OR HER SETTLEMENT WITH THE DEBTOR.

The parties shall also be deemed expressly to have waived any and all provisions, rights and benefits conferred by any law of any state or territory of the United States, or principle of common law, which is similar, comparable, or equivalent to California Civil Code Section 1542 or that would otherwise limit the releases and waivers contained in this Agreement. The parties each acknowledge that the foregoing waiver was separately bargained for and an integral aspect of the settlement of which this release is a part.

**Article V.**

**COVENANTS**

**Section 5.01 Covenants and Acknowledgements.**

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(a) Each of Seller and the SPAC acknowledges and agrees that liabilities incurred by the SPAC after the Closing will remain the responsibility of the SPAC and will be paid or otherwise settled by the SPAC. The SPAC will be responsible for the payment of Covered Expenses and future obligations related to the ongoing operation of the SPAC, including the Deferred Liabilities and Ordinary Course Expenses.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b) Upon the execution and delivery of this Agreement by the parties hereto, the SPAC, ReserveOne and R-1 Holdings agree to execute documents sufficient to terminate the Business Combination Agreement.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(c) Promptly after the Closing, ReserveOne agrees to pay or settle all of its accrued liabilities as of Closing.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(d) If, prior to the Closing, Seller or the SPAC enters into any Other Agreement (or amends or modifies any existing Other Agreement) with any Person for the purchase or transfer of Class B Shares (or Class A Shares issuable upon conversion thereof) on terms that provide for a per-share purchase price that is lower than $3.33 per share, then Seller shall promptly (and in any event within five (5) business days) provide Buyer with written notice thereof together with a copy of such Other Agreement or amendment, and Buyer shall thereupon be entitled (exercisable by written notice to Seller within ten (10) business days of receipt of such notice, in Buyer's sole discretion) to elect to have the corresponding terms of this Agreement amended (with retroactive effect to the date hereof) to incorporate such more favorable terms. For the avoidance of doubt, the most-favored-nation right set forth in this Section 5.01(d) is limited to per-share purchase price.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(e) Between the date hereof and the Closing, neither the SPAC nor Seller shall have: (i) entered into, or agreed to enter into, any new business combination agreement, merger agreement, share purchase agreement, or similar binding agreement contemplating an initial business combination of the SPAC; (ii) made any public announcement of, or entered into any letter of intent, term sheet, memorandum of understanding, or similar agreement regarding, an intended business combination involving the acquisition of, or the conversion of the SPAC's assets into, Bitcoin, Ether, other cryptocurrency, digital assets, or other speculative non-operating assets; or (iii) adopted, or announced the intention to adopt, any investment policy, treasury policy, or similar policy contemplating the deployment of any material portion of the SPAC's assets (including any portion of the Trust Account) into Bitcoin, Ether, other cryptocurrency, digital assets, or other speculative non-operating assets, in each case without Buyer's prior written consent (such consent not to be unreasonably withheld, conditioned, or delayed).

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(f) Between the date hereof and the Closing, other than the Extraordinary General Meeting of Shareholders, scheduled for June 15, 2026, called by that definitive proxy statement dated May 13, 2026, for the purpose of considering the Business Combination Agreement, and which the SPAC will cancel pursuant to <u>Section 5.01(h)</u> of this Agreement, neither the SPAC nor Seller shall have called, scheduled, or held any meeting of shareholders, or solicited any vote, written consent, or proxy, with respect to (i) the Business Combination Agreement (whether to approve, consummate, ratify, or otherwise) or (ii) any matter inconsistent with the termination of the Business Combination Agreement or the consummation of the transactions contemplated by this Agreement; <u>provided</u>, that for the avoidance of doubt, the calling or scheduling of an extraordinary, special, or annual meeting for purposes of the Amendments, election of directors, ratification of auditors and any other matters typically conducted at an annual meeting of shareholders as mandated by SEC requirements or Cayman Island law shall be permitted pursuant to this <u>Section 5.01(f)</u>.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(g) Upon execution and delivery of this Agreement, the Additional Agreements, and funding of the Escrow Account, the SPAC, ReserveOne, and R-1 Holdings, agree to promptly terminate and withdraw the Registration Statement and make all necessary filings with the SEC to do so.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(h) Upon execution and delivery of this Agreement, the Additional Agreements, and funding of the Escrow Account, the SPAC will promptly cancel its Extraordinary General Meeting of Shareholders, scheduled for June 15, 2026, called for purposes of considering the Business Combination Agreement, among other matters.

**Article VI.**

**MISCELLANEOUS**

**Section 6.01 Expenses. Except as otherwise specifically stated herein, all costs and expenses incurred in connection with this Agreement and the transactions contemplated hereby shall be paid by the party incurring such costs and expenses.**

**Section 6.02 Further Assurances. Following the Closing, each of the parties hereto shall, and shall cause their respective Affiliates to, execute and deliver such additional documents, instruments, conveyances, and assurances and take such further actions as may be reasonably required to carry out the provisions hereof and give effect to the transactions contemplated by this Agreement.**

**Section 6.03 Notices. All notices, Claims, and other communications hereunder shall be in writing and shall be deemed to have been given (a) when delivered by hand (with written confirmation of receipt); (b) when received by the addressee if sent by a nationally recognized overnight courier (receipt requested); or (c) on the date sent by email if sent during normal business hours of the recipient, and on the next business day if sent after normal business hours of the recipient. Such communications must be sent to the respective parties at the following addresses (or at such other address for a party as shall be specified in a notice given in accordance with this Section 6.03):**

**If to Buyer:**

At the address set forth on the Buyer's signature page hereto.

**If to Seller, the SPAC, ReserveOne or R-1 Holdings:**

c/o CC Capital Partners, LLC

200 Park Avenue, 58th Floor

New York, NY 10166

Attn: Thomas Boychuk

Email: [\*\*\*]

**Section 6.04 Headings. The headings in this Agreement are for reference only and shall not affect the interpretation of this Agreement.**

**Section 6.05 Severability. If any term or provision of this Agreement is invalid, illegal, or unenforceable in any jurisdiction, such invalidity, illegality, or unenforceability shall not affect any other term or provision of this Agreement or invalidate or render unenforceable such term or provision in any other jurisdiction. Upon a determination that any term or other provision is invalid, illegal, or unenforceable, the parties hereto shall negotiate in good faith to modify the Agreement so as to effect the original intent of the parties as closely as possible in a mutually acceptable manner in order that the transactions contemplated hereby be consummated as originally contemplated to the greatest extent possible.**

**Section 6.06 Entire Agreement. This Agreement and the documents to be delivered hereunder constitute the sole and entire agreement of the parties to this Agreement with respect to the subject matter contained herein, and supersede all prior and contemporaneous understandings and agreements, both written and oral, with respect to such subject matter. In the event of any inconsistency between the terms and provisions in the body of this Agreement and those in the documents delivered in connection herewith and the Exhibits hereto, the terms and provisions in the body of this Agreement shall control.**

**Section 6.07 Successors and Assigns. This Agreement shall be binding upon and shall inure to the benefit of the parties hereto and their respective successors and permitted assigns. None of the parties may assign their respective rights or obligations hereunder without the prior written consent of the other parties. No assignment shall relieve the assigning party of any of its obligations hereunder.**

**Section 6.08 No Third-Party Beneficiaries. Except as provided in <u>Article IV</u>, this Agreement is for the sole benefit of the parties hereto and their respective successors and permitted assigns, and nothing herein, express or implied, is intended to or shall confer upon any other Person any legal or equitable right, benefit, or remedy of any nature whatsoever under or by reason of this Agreement.**

**Section 6.09 Amendment and Modification. This Agreement may be amended, modified, or supplemented only by a written agreement signed by each party hereto.**

**Section 6.10 Cumulative Remedies. The rights and remedies provided in this Agreement cumulative and are in addition to and not in substitution for any other rights and remedies available at law or in equity or otherwise.**

**Section 6.11 Waiver. No waiver by any party of any of the provisions hereof shall be effective unless explicitly set forth in writing and signed by the party so waiving. No waiver by any party shall operate or be construed as a waiver in respect of any failure, breach, or default not expressly identified by such written waiver, whether of a similar or different character, and whether occurring before or after that waiver. No failure to exercise, or delay in exercising, any right, remedy, power, or privilege arising from this Agreement shall operate or be construed as a waiver thereof; nor shall any single or partial exercise of any right, remedy, power, or privilege hereunder preclude any other or further exercise thereof or the exercise of any other right, remedy, power, or privilege.**

**Section 6.12 Governing Law. All matters arising out of or relating to this Agreement and all related documents shall be governed by and construed in accordance with the internal laws of the State of New York without giving effect to any choice or conflict of law provision.**

**Section 6.13 Submission to Jurisdiction. Any Action arising out of or related to this Agreement or the transactions contemplated hereby may be instituted only in the federal courts of the United States of America or the courts of the State of New York, in each case located in the Borough of Manhattan in New York City, State of New York, and each party irrevocably submits to the exclusive jurisdiction of such courts in any such Action. EACH OF THE PARTIES HERETO HEREBY AGREES TO WAIVE ANY RIGHT TO TRIAL BY JURY WITH RESPECT TO ANY CLAIM, COUNTERCLAIM OR ACTION ARISING OUT OF OR RELATING TO THIS AGREEMENT.**

**Section 6.14 Specific Performance. The parties agree that irreparable damage would occur if any provision of this Agreement were not performed in accordance with the terms hereof and that the parties shall be entitled to seek specific performance of the terms hereof, in addition to any other remedy to which they are entitled at law or in equity.**

**Section 6.15 Counterparts. This Agreement may be executed in counterparts, each of which shall be deemed an original, but all of which together shall be deemed to be one and the same agreement. A signed copy of this Agreement delivered by facsimile, email, or other means of electronic transmission shall be deemed to have the same legal effect as delivery of an original signed copy of this Agreement.**

**Section 6.16 Waiver Against Trust. Buyer hereby agrees, on behalf of itself and the other members of the Buyer Parties, that, notwithstanding anything to the contrary in this Agreement, solely in its capacity as a holder of Transferred Shares (and not in its capacity as a holder of any Class A Shares constituting Public Shares), neither Buyer nor any other member of the Buyer Parties shall have or shall at any time thereafter have any Claim of any kind in or to any monies in the Trust Account or distributions therefrom, or make any Claim against the Trust Account (including any distributions therefrom), regardless of whether such Claim arises as a result of, in connection with or relating in any way to, this Agreement or any proposed or actual business relationship between Seller, the SPAC, ReserveOne, R-1 Holdings or their respective Affiliates, on the one hand, and Buyer or its Affiliates, on the other hand, or any other matter, and regardless of whether such Claim arises based on contract, tort, equity or any other theory of legal liability (collectively, the "Trust Released Claims"). Buyer, on behalf of itself and the other member of the Buyer Parties, hereby irrevocably waives any Trust Released Claims that Buyer or any other member of the Buyer Parties may have against the Trust Account (including any distributions therefrom) now or in the future and will not seek recourse against the Trust Account (including any distributions therefrom) for any reason whatsoever (including for an alleged breach of this Agreement or any other agreement with Buyer, Seller, the SPAC, ReserveOne, R-1 Holdings or their respective Affiliates). Buyer agrees and acknowledges that such irrevocable waiver by it is material to this Agreement and specifically relied upon by Seller and its Affiliates to induce it to enter into this Agreement, and Buyer further intends and understands such waiver to be valid, binding and enforceable against Buyer and each other member of the Buyer Parties under applicable law. Notwithstanding anything to the contrary in this <u>Section 6.16</u>, the foregoing waiver shall not limit, waive, release, or otherwise affect Buyer's right (in its capacity as a public shareholder of the SPAC) to receive (i) pro-rata distributions from the Trust Account in respect of any Class A Shares constituting Public Shares (but, for the avoidance of doubt, excluding the Transferred Shares) in connection with any redemption of such Class A Shares constituting Public Shares pursuant to the SPAC's organizational documents or in connection with the dissolution or liquidation of the SPAC, and (ii) any distributions in respect of any termination fee, expense reimbursement, or similar payment received by the SPAC from any third party that is, by the terms of such payment or by operation of the SPAC's organizational documents or the Trust Agreement, payable to or distributable among the holders of Class A Shares generally, <u>provided</u> that the foregoing limitation shall not limit any obligation of Buyer pursuant to any separate non-redemption agreement, including any Voting Support and Non-Redemption Agreement, relating to Class A Shares to which it is a party.**

**Section 6.17 Notwithstanding anything in this Agreement to the contrary, each of the Seller Parties (i) shall not publicly disclose the name of Buyer or any of its Affiliates or advisers, or include the name of Buyer or any of its Affiliates or advisers in any press release, without the prior written consent of Buyer and (ii) shall not publicly disclose the name of Buyer or any of its Affiliates or advisers, or include the name of Buyer or any of its Affiliates or advisers in any filing with the SEC any regulatory agency or trading market, without the prior written consent of Buyer, except to the extent such disclosure is required by other laws, rules or regulations, or at the request of the staff of the SEC or other regulatory agency, in which case the Seller Parties shall provide Buyer with prior written notice (including by e-mail) of such permitted disclosure, and shall reasonably consult with Buyer regarding such disclosure. Buyer will promptly provide any information reasonably requested by the Seller Parties for any regulatory application or filing made or approval sought in connection with the transactions contemplated by this Agreement.**

 

*[Remainder of page intentionally left blank; signature pages follow]*

 

 

**IN WITNESS WHEREOF**, the SPAC has caused this Agreement to be executed as of the date first written above.

---

| |
|:---|
| **<u>SPAC</u>:** |
| **M3-BRIGADE ACQUISITION V CORP.** |
| By: |
| Name: |
| Title: |

---

*[Signature Page to Securities Purchase Agreement]*

**IN WITNESS WHEREOF**, Seller has caused this Agreement to be executed as of the date first written above.

---

| | |
|:---|:---|
| **<u>SELLER</u>:** | **<u>SELLER</u>:** |
| **MI7 SPONSOR, LLC** | **MI7 SPONSOR, LLC** |
| By: |  |
| Name: | Thomas Boychuk |
| Title: | Chief Financial Officer |

---

*[Signature Page to Securities Purchase Agreement]*

**IN WITNESS WHEREOF**, ReserveOne and R-1 Holdings have executed this Agreement as of the date first above written.

---

| | |
|:---|:---|
| **<u>RESERVEONE</u>:** | **<u>RESERVEONE</u>:** |
| **RESERVEONE, INC.** | **RESERVEONE, INC.** |
| By: |  |
| Name: | Jaime Leverton |
| Title: | Chief Executive Officer |
| **<u>R-1 HOLDINGS</u>:** | **<u>R-1 HOLDINGS</u>:** |
| **RESERVEONE HOLDINGS, INC.** | **RESERVEONE HOLDINGS, INC.** |
| By: |  |
| Name: | Jaime Leverton |
| Title: | Chief Executive Officer |

---

*[Signature Page to Securities Purchase Agreement]*

**IN WITNESS WHEREOF**, Buyer has executed o caused this Agreement to be executed by its duly authorized representative as of the date first above written.

---

| |
|:---|
| **<u>BUYER</u>**: |
| **[_____]** |
| By: |
| Name: |
| Title: |

---

**Address for Notices:**

[●]

*[Signature Page to Securities Purchase Agreement]*

 

 

**<u>Schedule A</u>**

<u>[●]</u> Class A Shares at $3.33 per share to be purchased by Buyer

<u>[●]</u> Aggregate Purchase Price for the Class A Shares to be purchased by Buyer

*[Schedule A to Securities Purchase Agreement]*

**<u>Schedule B</u>**

**<u>Deferred Liabilities</u>**

[\*\*\*]

*[Schedule B to Securities Purchase Agreement]*

**<u>Exhibit I</u>**

**<u>Terms and Conditions of Escrow Agreement</u>**

[\*\*\*]

*[Exhibit I to Securities Purchase Agreement]*

## Exhibit 10.3

**Exhibit 10.3**

**JOINDER AGREEMENT**

This Joinder Agreement (the "***Joinder Agreement***"), dated as of June 12, 2026, is executed by and between M3-Brigade Acquisition V Corp., a Cayman Islands exempted company (the "***Company***"), and the counterparty designated as "Buyer" in the signature page hereto ("***Buyer***"), in connection with that certain Registration Rights Agreement, dated as of July 31, 2024 (the "***Agreement***"), by and among the Company, MI7 Sponsor, LLC, a Delaware limited liability company (as assignee of M3-Brigade Sponsor V LLC) (the "***Sponsor***"), Cantor Fitzgerald & Co., and each person who has become a party thereto by entering into a joinder agreement in accordance with the terms thereof. Capitalized terms used but not defined herein shall have the meaning given to such terms in the Agreement.

By the execution of this Joinder Agreement, Buyer agrees as follows:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;1. Buyer is a party to that certain Securities Purchase Agreement, dated as of June 12, 2026, by and among the Sponsor, Buyer, the Company, ReserveOne, Inc. and ReserveOne Holdings, Inc. (the "**SPA**"), pursuant to which Buyer has agreed to purchase from the Sponsor a number of Class A ordinary shares, par value $0.0001 per share of the Company as specified in the SPA (the "***Transferred Shares***"). The Transferred Shares will be issued upon conversion of an equal number of the Sponsor's Class B ordinary shares, par value $0.001 per share of the Company and will be "Registrable Securities" as such term is defined in the Agreement.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;2. Upon the transfer of the Transferred Shares to Buyer, without any further action required, Buyer hereby automatically joins in, and agrees to become a party to and be bound by and subject to, the provisions of the Agreement.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;3. Any notice required or permitted by the Agreement shall be given to Buyer at the address listed below its name on the signature page hereto.

[*Remainder of Page Left Intentionally Blank*]

IN WITNESS WHEREOF, the undersigned has executed this Joinder Agreement as of the date set forth above.

---

| |
|:---|
| **BUYER:** |
| **[______________]** |
| By: |
| Name: |
| Title: |
| Address: |

---

---

| |
|:---|
| **ACKNOWLEDGED AND AGREED:** |
| **M3-BRIGADE ACQUISITION V CORP.** |
| By: |
| Name: |
| Title: |
| **CANTOR FITZGERALD & CO.** |
| By: |
| Name: |
| Title: |

---

*[Signature Page to Joinder Agreement to Registration Rights Agreement (Transferred Shares)]*

## Exhibit 10.4

**Exhibit 10.4**

**JOINDER AGREEMENT**

This Joinder Agreement (the "***Joinder Agreement***"), dated as of June 12, 2026, is executed by and between M3-Brigade Acquisition V Corp., a Cayman Islands exempted company (the "***Company***"), and the counterparty designated as "Buyer" in the signature page hereto ("***Buyer***"), in connection with that certain Letter Agreement, dated as of July 31, 2024 (the "***Agreement***"), by and among the Company, MI7 Sponsor, LLC, a Delaware limited liability company (as assignee of M3-Brigade Sponsor V LLC) (the "***Sponsor***"), the other parties thereto, and each person who has become a party thereto by entering into a joinder agreement in accordance with the terms thereof. Capitalized terms used but not defined herein shall have the meaning given to such terms in the Agreement.

By the execution of this Joinder Agreement, Buyer agrees as follows:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;1. Buyer is a party to that certain Securities Purchase Agreement, dated as of June 12, 2026, by and among the Sponsor, Buyer, the Company, ReserveOne, Inc. and ReserveOne Holdings, Inc. (the "**SPA**"), pursuant to which Buyer has agreed to purchase from the Sponsor a number of Class A ordinary shares, par value $0.0001 per share of the Company as specified in the SPA (the "***Transferred Shares***"). The Transferred Shares will be issued upon conversion of an equal number of the Sponsor's Class B ordinary shares, par value $0.001 per share of the Company and will be "Founder Shares" as such term is defined in the Agreement.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;2. Upon the transfer of the Transferred Shares to Buyer, without any further action required, Buyer hereby automatically joins in, and agrees to become a party to and be bound by and subject to, the provisions of the Agreement relating to (i) the voting, non-redemption, Trust Account waiver, liquidating distributions and transfer restrictions applicable to the Transferred Shares to the same extent as such provisions set forth in Sections 1, 2, 6 and 7 of the Agreement apply to the Sponsor with respect to the Sponsor's ownership of Founder Shares, and (ii) defined terms, governing law and other provisions of general applicability as set forth in Sections 11 and 13 through 20 of the Agreement. For the avoidance of doubt, Buyer shall not be subject to the provisions of the Agreement with respect to any Offering Shares (as defined in the Agreement) that it may own.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;3. The undersigned hereby acknowledge and agree that that upon the transfer of the Transferred Shares, Buyer and the Transferred Shares shall be subject only to the provisions set forth in Section 1, 2, 6, 7, 11 and 13 through 20 and for the avoidance of doubt, shall not be subject to any provision contained in any other Section of the Agreement.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;4. Each of the Company and the Sponsor represent and warrant to Buyer that each of the Company and the Sponsor have obtained all consents, approvals, waivers or authorizations required to be obtained from any individual, corporation, partnership, joint venture, limited liability company, governmental authority, unincorporated organization, trust, association, or other entity in connection with the limited joinder contemplated hereby and the matters contemplated herein.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;5. Any notice required or permitted by the Agreement shall be given to Buyer at the address listed below its name on the signature page hereto.

IN WITNESS WHEREOF, the undersigned has executed this Joinder Agreement as of the date set forth above.

---

| |
|:---|
| **BUYER:** |
| **[______________]** |
| By: |
| Name: |
| Title: |
| Address: |

---

*[Signature Page to Joinder Agreement to Letter Agreement (Transferred Shares)]*

---

| |
|:---|
| **ACKNOWLEDGED AND AGREED:** |
| **MI7 SPONSOR, LLC** |
| By: |
| Name: |
| Title: |
| **M3-BRIGADE ACQUISITION V CORP.** |
| By: |
| Name: |
| Title: |

---

*[Signature Page to Joinder Agreement to Letter Agreement (Transferred Shares)]*

## Exhibit 10.5

**Exhibit 10.5**

**VOTING SUPPORT AND NON-REDEMPTION AGREEMENT**

THIS VOTING SUPPORT AND NON-REDEMPTION AGREEMENT (this "**Agreement**"), dated as of June 12, 2026, is made and entered into by and among the undersigned shareholder (the "**Buyer**") and M3-Brigade Acquisition V Corp., a Cayman Islands exempted company incorporated with limited liability (the "**SPAC**"), MI7 Sponsor, LLC, a Delaware limited liability company (the "**Seller**"), ReserveOne, Inc., a Delaware corporation ("**ReserveOne**"), and ReserveOne Holdings, Inc., a Delaware corporation ("**R-1 Holdings**").

Unless otherwise stated herein, capitalized terms used in this Agreement shall have the meanings ascribed to them in the prospectus relating to the registration statement on Form S-1 of M3-Brigade Acquisition V Corp. first filed with the U.S. Securities and Exchange Commission (the "**SEC**") on June 5, 2024 (Registration No. 333-279951), as amended and as declared effective on July 31, 2024, and as may be supplemented or post-effectively amended from time to time.

**RECITALS**

**WHEREAS**, the SPAC was incorporated on March 12, 2024, and consummated an initial public offering of its units on August 2, 2024, generating gross proceeds of $287,500,000 (the "**IPO**");

**WHEREAS**, the Class A ordinary shares, par value $0.0001 per share, constituting Public Shares of the SPAC ("**Class A Shares**"), and associated warrants to purchase Class A Shares ("**Listed Warrants**"), and units of the SPAC are listed on The Nasdaq Stock Market LLC ("**Nasdaq**") under the trading symbols "MBAV", "MBAVW" and "MBAVU", respectively;

**WHEREAS**, the Seller is the sponsor of the SPAC and owns and holds 8,337,500 private placement warrants issued by the SPAC (the "**Private Placement Warrants**");

**WHEREAS**, the SPAC, ReserveOne, R-1 Holdings and certain other parties entered into a business combination agreement dated July 7, 2025 (the "**Business Combination Agreement**");

**WHEREAS**, the SPAC and Cantor Fitzgerald & Co., as representative of the underwriters thereto, are parties to that certain Underwriting Agreement, dated as of July 31, 2024 (the "**Underwriting Agreement**");

**WHEREAS**, the SPAC and Continental Stock Transfer & Trust Co., as trustee (the "**Trustee**"), are parties to that certain Investment Management Trust Agreement, dated as of July 31, 2024 (the "**Trust Agreement**");

**WHEREAS**, the SPAC intends to amend the SPAC's Amended and Restated Memorandum and Articles of Association (the "**Articles**") substantially in the form attached hereto as <u>Exhibit I</u> (the "**Charter Amendment**");

**WHEREAS**, the SPAC intends to amend the Trust Agreement to incorporate provisions for the release of interest from the SPAC's trust account ("**Trust Account**") as permitted by the Charter Amendment (the "**Trust Amendment**" and together with the Charter Amendment, the "**Amendments**");

**WHEREAS**, the Buyer, the SPAC, the Seller, ReserveOne and R-1 Holdings desire to enter into this Agreement whereby the Buyer agrees, among other things, (i) to vote the Buyer Shares (as defined herein) in favor of the proposed Amendments, (ii) not to exercise any right to redeem the Buyer Shares in connection with the Amendments, and (iii) to reverse and revoke any prior redemption elections made with respect to the Buyer Shares in connection with the Amendments;

**WHEREAS,** as consideration for the Buyer to enter into this Agreement, the Seller agrees to sell, assign, transfer, convey and deliver to the Buyer the number of the Seller's Private Placement Warrants set forth on the signature page hereto (the "**Transferred Warrants**");

**WHEREAS**, the SPAC, the Seller, ReserveOne and R-1 Holdings are entering into similar agreements with certain other SPAC shareholders (the "**Other Agreements**"); and

**WHEREAS**, in connection with this Agreement, certain of the parties hereto are, as of even date herewith, are entering into the following additional agreements (the "**Additional Agreements**"):

● Mutual Termination Agreement, by and between the SPAC and ReserveOne (the "**BCA Termination Agreement** ");

● Joinder Agreement by and between the SPAC and Buyer (the "**Registration Rights Joinder**") in connection with that certain Registration Rights Agreement, dated as of July 31, 2024, by and among the SPAC, the Seller (as assignee of M3-Brigade Sponsor V LLC) and Cantor Fitzgerald & Co. (the "**Registration Rights Agreement** ");

● Joinder Agreement, by and between the SPAC and Buyer (the "**Letter Agreement Joinder**") in connection with that certain Letter Agreement, dated as of July 31, 2024, by and among the SPAC, the Seller, and the other parties thereto (the "**Letter Agreement** "); and

● Assignment of Private Placement Warrants, by and between the Seller and Buyer (the "**Warrant Assignment** ").

**NOW, THEREFORE**, in consideration of the mutual covenants and agreements hereinafter set forth and for other good and valuable consideration, the receipt and sufficiency of which are hereby acknowledged, the parties hereto, intending to be legally bound by the terms hereof, agree as follows:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;1. <u>Buyer's Ownership</u>. The Buyer represents and warrants that, as of the date hereof, it is the "beneficial owner" (as defined in Rule 13d-3 under the Securities Exchange Act of 1934, as amended (the "**Exchange Act**")) of the number of Class A Shares set forth on the signature page hereto (the "**Buyer Shares**"). Furthermore, the Buyer represents and warrants that as of the date hereof, the Buyer and its Affiliates own the Buyer Shares, which shares are subject to the covenants set forth in this Agreement, whether or not such shares are "beneficially owned" under the Exchange Act. For purposes of this Agreement, (i) the term "**Affiliate**" or "**Affiliates**" of a Person means any other Person that directly or indirectly, through one or more intermediaries, controls, is controlled by, or is under common control with, such Person, (ii) the term "**control**" (including the terms "controlled by" and "under common control with") means the possession, directly or indirectly, of the power to direct or cause the direction of the management and policies of a Person, whether through the ownership of voting securities, by contract, or otherwise, and (iii) the term "**Person"** means an individual, corporation, partnership, joint venture, limited liability company, governmental authority, unincorporated organization, trust, association, or other entity. In the event that Buyer does not own any Class A Shares as of the date hereof and is executing this Agreement in anticipation of its potential acquisition of Class A Shares following the date hereof, Buyer shall provide prompt written notice to the SPAC and the Seller of its acquisition of any Class A Shares after the date hereof, and upon receipt of such notice, such Class A Shares shall be deemed to constitute "Buyer Shares" for all purposes under this Agreement. The amount of Transferred Warrants to be assigned to Buyer shall be equal to the product of (a) 0.5 multiplied by (b) the number of Buyer Shares owned by Buyer after giving effect to such acquisition. Buyer's signature page to this Agreement shall, without further action on the part of the SPAC, Seller or Buyer, be deemed to be revised to reflect (i) the Buyer Shares owned by Buyer following such acquisition and (ii) the amount of Transferred Warrants to be assigned to Buyer based on the amount of Buyer Shares owned following such acquisition.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;2. <u>Covenant to Vote</u>. In consideration of the terms of this Agreement, with respect to all Class A Shares owned by the Buyer and its Affiliates as of the record date for any meeting of the SPAC's shareholders, solely in their respective capacity as a shareholder of the SPAC, at any meeting of the SPAC's shareholders, or in any other meeting or circumstance in which the vote, consent or other approval of the SPAC's shareholders is sought to approve the Amendments (any such meeting, a "**Covered Meeting**"), the Buyer and its Affiliates hereby irrevocably agree that if a meeting is held, to be present for any such meeting, and to vote (in person or by proxy), or, if voting is permitted by written consent, to execute and deliver a written consent covering, all Class A Shares owned by the Buyer and its Affiliates in favor of the Amendments and cause all such shares to be counted as present thereat for purposes of establishing a quorum. For the avoidance of doubt, nothing in this Agreement shall be construed to require Buyer and its Affiliates to vote in favor of any other proposal other than the Amendments.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;3. <u>Matters Related to Voting Commitment</u>. In consideration of the terms of this Agreement, the Buyer further agrees, with respect to all Class A Shares owned as of the date hereof or hereafter acquired by the Buyer or its Affiliates, solely in their respective capacity as a shareholder of the SPAC, during the period from, and including, the date hereof through, and including, the date on which the Amendments are approved by the SPAC shareholders:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(a) not to deposit, and to cause its Affiliates not to deposit, any such Class A Shares in a voting trust or subject any such Class A Shares to any arrangement or agreement with respect to the voting of such Class A Shares, unless specifically requested to do so by the SPAC; and

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b) not to make, or in any manner participate in, directly or indirectly, a "solicitation" of "proxies" or consents (as such terms are used in the rules of the SEC) or powers of attorney or similar rights to vote, or seek to advise or influence any Person with respect to the voting of any capital shares of the SPAC in connection with any vote or other action with respect to the Amendments, other than to recommend that shareholders of the SPAC vote in favor of the Amendments and any other proposal the approval of which is a condition to the obligations of the parties hereunder.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;4. <u>Non-Redemption Agreement</u>.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(a) The Buyer and its Affiliates hereby waive any right that they may have to elect to have the SPAC redeem any Buyer Shares owned as of the date hereof in connection with the Amendments and covenants and agrees not to redeem or otherwise exercise any right to redeem the Buyer Shares in connection with the Amendments and to reverse and revoke any prior redemption elections made with respect to the Buyer Shares in connection with the Amendments. For the avoidance of doubt, nothing in this Agreement shall be construed to require the Buyer and its Affiliates to waive any redemption right that they may have to elect to have the SPAC redeem any Buyer Shares in connection with any matter other than the vote regarding the approval of the Amendments, including, for the avoidance of doubt, the approval of any future amendment to the Articles or in connection with any business combination involving the SPAC.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b) Notwithstanding the foregoing, nothing in this <u>Section 4</u> shall prohibit the Buyer or its Affiliates from redeeming such number of Class A Shares as is necessary to ensure that the beneficial ownership of the Buyer and its Affiliates does not exceed 9.9% of the Class A Shares outstanding immediately following the effective date of the Amendments (after giving effect to all redemptions in connection therewith) (the "**9.9% Ownership Limit**"), taking into account, for purposes of calculating such beneficial ownership, any Class A founder shares issued or issuable to the Buyer or its Affiliates upon conversion of any Class B ordinary shares, par value $0.0001 per share, of the SPAC, to the extent received in a private sale with the Seller. Any redemption or Transfer effected solely to comply with the 9.9% Ownership Limit shall not constitute a breach of this Agreement. To the extent Buyer or its Affiliates redeem any Class A Shares pursuant to this <u>Section 4(b)</u>, Buyer shall provide prompt written notice to the SPAC and Seller of such redemption, and upon receipt of such notice, the number of Class A Shares deemed to constitute "Buyer Shares" for all purposes under this Agreement shall be reduced by the number of Class A Shares redeemed. The amount of Transferred Warrants to be assigned to Buyer shall be equal to the product of (a) 0.5 multiplied by (b) the number of Buyer Shares owned by Buyer after giving effect to such redemption. If Buyer acquires Class A Shares following the date hereof as contemplated above, Buyer's signature page to this Agreement shall, without further action on the part of Seller or Buyer, be deemed to be revised to reflect (i) the Buyer Shares owned by Buyer following such redemption and (ii) the amount of Transferred Warrants to be assigned to Buyer based on the amount of Buyer Shares owned following such redemption.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;5. <u>No Hedging or Transfers of the Buyer Sh</u>ares. The Buyer covenants and agrees that neither it, nor any Person or entity acting on its behalf or pursuant to any understanding with it, will, from the execution of this Agreement until the later of (a) the first business day following the effective date of the Amendments or (b) the expiration of any redemption rights held as a holder of Class A Shares with respect to the Amendments: (i) engage in any hedging transactions or Short Sales (as defined herein) with respect to securities of the SPAC, (ii) offer for sale, sell (including Short Sales), transfer (including by operation of law), place a lien on, pledge, convert, assign or otherwise dispose of (including by gift, merger, tendering into any tender offer or exchange offer or otherwise) or encumber (collectively, a "**Transfer"**), or enter into any contract, option, derivative, hedging or other agreement, arrangement, undertaking or understanding (including any profit-sharing arrangement) with respect to, or consent to, a direct or indirect Transfer of, any or all of the Buyer Shares, and any other Class A Shares owned by the Buyer and its Affiliates, or (iii) take any action that would have the effect of preventing or materially delaying the performance of its obligations hereunder. Notwithstanding anything to the contrary in this <u>Section 5</u> (and subject to <u>Section 25</u>), in the event that (1) any meeting of the SPAC's shareholders is held in which the vote, consent or other approval of the SPAC's shareholders is sought to approve the Amendments (and such meeting is not adjourned prior to any vote to approve the Amendments being taken) and the Amendments are not approved by the requisite vote of the SPAC's shareholders, or (2) the Closing does not occur by 11:59 p.m. EST on August 2, 2026, then any restrictions on the Transfer of the Buyer Shares in this <u>Section</u> 5 shall have no further force or effect. For purposes of this Agreement, "**Short Sales**" shall include, without limitation, (A) all "short sales" as defined in Rule 200 promulgated under Regulation SHO under the Exchange Act, (B) all types of direct and indirect stock pledges (other than pledges in the ordinary course of business as part of prime brokerage or other similar financing arrangements), forward sale contracts, options, puts, calls, swaps and similar arrangements (including on a total return basis), and (C) sales and other transactions through non-U.S. broker dealers or foreign regulated brokers. Notwithstanding the foregoing, the restrictions in this <u>Section 5</u> shall not prohibit, and shall not be deemed breached by: (1) any redemption or Transfer of Class A Shares necessary to comply with the 9.9% Ownership Limit set forth in <u>Section 4</u>; (2) any Transfer to an Affiliate of the Buyer that executes a joinder agreeing to be bound by the terms of this Agreement; (3) any pledge or margin arrangement existing as of the date hereof, or entered into in the ordinary course as part of prime brokerage or similar financing arrangements; and (4) any hedging or derivative transaction, so long as the Buyer retains beneficial ownership of, and the sole power to vote, the Buyer Shares and any other Class A Shares owned by Buyer in accordance with <u>Section 2</u>.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;6. <u>Charter Amendments</u>. The terms of the Charter Amendment include the following:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(a) extending the date by which the SPAC must consummate an initial business combination by 12 months (to August 2, 2027);

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b) permitting the SPAC, following the effective date of the Amendments after all redemptions pursuant to the exercise of redemption rights arising in connection with the Amendments have been settled, to withdraw up to an aggregate amount of interest earned on the funds held in the Trust Account in an amount equal to $0.10 for each Class A Share issued in the IPO that is not redeemed and remains outstanding immediately following the effective date of the Amendments, of which (i) $1,000,000 will be used to pay the Ordinary Course Expenses (as defined herein) and (ii) any amounts in excess of such $1,000,000 will be used to pay Covered Expenses (as defined herein);

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(c) changing the SPAC's legal name to Velos Acquisition I Corp.;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(d) removing Article 49.12 (fairness opinion requirement) from the Articles in its entirety; and

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(e) such other modifications to the Articles as may be necessary to give effect to amendments (a) – (d).

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;7. <u>Grant of Proxy</u>. In the event that the Buyer fails to vote its Class A Shares by proxy by the date that is one (1) business day prior to the date of the Covered Meeting, the Buyer hereby grants to the SPAC, and any individual designated in writing by the SPAC, a proxy and power of attorney (with full power of substitution and resubstitution) for and in such Buyer's name, solely to vote all Class A Shares owned by Buyer in favor of the Amendments in the manner contemplated by <u>Section 2</u>. Such proxy shall be coupled with an interest, irrevocable, shall be limited to curing the Buyer's voting obligations with respect to the Amendments, and shall expire automatically upon shareholder approval of the Amendments.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;8. <u>Transferred Warrants</u>.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(a) Subject to the terms and conditions set forth herein, in consideration of the representations, covenants and agreements of the Buyer contained in this Agreement, at the Closing (as defined herein), the Seller shall assign, transfer, convey and deliver to the Buyer, all of the Seller's right, title, and interest in and to the Transferred Warrants pursuant to the Warrant Assignment being executed and delivered simultaneously with this Agreement. The Transferred Warrants shall be free and clear of any mortgage, pledge, lien, charge, security interest, claim, or other encumbrance ("**Encumbrance**"), other than any encumbrances that may exist as a result of applicable securities laws, the Letter Agreement, the Registration Rights Agreement, the Underwriting Agreement, and the Articles and other governing documents of the SPAC, as amended by the Amendments (collectively, the "**Permitted Encumbrances**").

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b) The SPAC shall deliver a corresponding instruction to the SPAC's transfer agent or registered office (as the case may be), to update its records accordingly, and, if requested or required by such transfer agent or registered office (as the case may be), the SPAC will cause its counsel to issue an opinion to such transfer agent that the sale of the Transferred Warrants may be made without registration under the Securities Act of 1933, as amended (the "**Securities Act**").

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(c) The SPAC shall register the resale of the Transferred Warrants under the Securities Act pursuant to the terms and conditions of the Registration Rights Agreement. The Buyer shall be required to become a party to the Letter Agreement and the Registration Rights Agreement solely with respect to the Transferred Warrants, pursuant to the Letter Agreement Joinder and the Registration Rights Joinder, respectively.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(d) Buyer shall provide all other deliverables that reasonably may be required for the execution, delivery, and performance of this Agreement and the transactions contemplated herein.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;9. <u>Investment Purpose</u>. The Buyer is acquiring the Transferred Warrants solely for its own account for investment purposes and not with a view to, or for offer or sale in connection with, any distribution thereof. The Buyer acknowledges that the Transferred Warrants are not registered under the Securities Act, or registered under any state securities laws, and that the Transferred Warrants may not be transferred or sold except pursuant to the registration provisions of the Securities Act, or pursuant to an applicable exemption therefrom and subject to state securities laws and regulations, as applicable.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;10. <u>Accredited Investor</u>. The Buyer hereby represents and warrants that it is an "accredited investor" as that term is defined in Rule 501(a) of Regulation D under the Securities Act. The Buyer has such knowledge and experience in financial and business matters that it is capable of evaluating the merits and risks of an investment in the securities offered under this Agreement, is making the investment for its own account (or for one or more accounts with respect to which it exercises sole investment discretion) and for investment purposes only and not with a view to distribution, is able to bear the economic risk of such investment, and can afford a complete loss of such investment.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;11. <u>SPAC Liabilities</u>.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(a) The closing of the transactions contemplated by this Agreement (the "**Closing**") shall take place upon the effective date of the Amendments (the "**Closing Date**"). As of the Closing Date, the SPAC will have no accrued and unpaid liabilities (including all known, estimated, contingent or deferred liabilities of the SPAC, regardless of whether set forth on the SPAC's balance sheet) except for (i) the accrued expenses that are due and payable as of the Closing Date (the "**Covered Expenses**"), which will be paid promptly after the Closing Date, (ii) the deferred liabilities set forth on <u>Schedule A</u> hereto (collectively, the "**Deferred Liabilities**") that are due and payable upon the consummation of the SPAC's business combination, and (iii) Ordinary Course Expenses (as defined herein) which will be paid in the ordinary course.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b) As of the Closing, except for Covered Expenses, Deferred Liabilities or Ordinary Course Expenses, (i) there will be no unpaid compensation owed by the SPAC or Seller to any officers, directors or advisors of the SPAC, and (ii) the SPAC has no other tax liability or obligations outstanding, other than any accrued franchise or similar taxes owed to the applicable authorities in the Cayman Islands, which have not yet become due and payable. As of the Closing Date, the Covered Expenses, the Deferred Liabilities and Ordinary Course Expenses will constitute all liabilities of the SPAC (whether accrued, disputed, contingent, or otherwise, and whether due or to become due), and represent all accrued liabilities known to Seller. Except for the (x) the Underwriting Agreement, (y) the Engagement Letter dated June 11, 2025, between the SPAC and Lincoln Financial LLC (the "**Lincoln Engagement Letter**"), and (z) the Sponsor Notes (as defined in Schedule A attached hereto), Seller has no agreement with any third party to pay, or cause the SPAC to pay, any fee contingent on consummation of a business combination. Notwithstanding the foregoing, expenses incurred by the SPAC in the ordinary course, including without limitation with respect to legal, accounting, printing, insurance, trust and stock transfer services, not in excess of $1,000,000 in the aggregate (the "**Ordinary Course Expenses**") shall not cause the representations and warranties contained in this <u>Section 11</u> to be deemed to be incorrect in any material respect.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;12. <u>Registration Rights.</u> As soon as practicable following the Closing (and in any event within forty-five (45) days following the Closing), the SPAC shall prepare and file with the SEC a Registration Statement on Form S-1 (the "**Registration Statement**") covering the resale of all Class A Shares the Buyer purchased from Cantor Fitzgerald & Co. , if any, for an offering to be made on a continuous basis pursuant to Rule 415 promulgated by the SEC pursuant to the Securities Act. The SPAC shall use its commercially reasonable efforts to cause the Registration Statement to be declared effective by the SEC as promptly as possible after the filing thereof and shall use its commercially reasonable efforts to keep the Registration Statement continuously effective under the Securities Act, through one or more post-effective amendments to such Registration Statement or any required prospectus supplements, until the date that all such shares included in the Registration Statement have been sold or can be sold publicly under Rule 144 by the Buyer without volume limitations and without the requirement that there be adequate current public information with regards to the SPAC. Upon notification by the SEC that a Registration Statement will not be reviewed or is no longer subject to further review and comments, the SPAC shall request acceleration of such Registration Statement within five (5) trading days after receipt of such notice. It shall be a condition precedent to the obligations of the SPAC to complete the registration pursuant to this <u>Section 12</u> that the Buyer furnish to the SPAC such information reasonably requested by the SPAC to effect such registration and the Buyer complete and execute such documents in connection with such registration as the SPAC may reasonably request.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;13. <u>Covenants and Acknowledgements</u>.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(a) Each of the Seller and the SPAC acknowledges and agrees that liabilities incurred by the SPAC after the Closing will remain the responsibility of the SPAC and will be paid or otherwise settled by the SPAC. The SPAC will be responsible for the payment of Covered Expenses and future obligations related to the ongoing operation of the SPAC, including the Deferred Liabilities and Ordinary Course Expenses.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b) Upon the execution and delivery of this Agreement by the parties hereto, the SPAC, ReserveOne and R-1 Holdings agree to execute and deliver the BCA Termination Agreement.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(c) Promptly after the Closing, ReserveOne agrees to pay or settle all of its accrued liabilities as of the Closing Date.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(d) If, prior to the Closing, Seller or the SPAC enters into any Other Agreement (or amends or modifies any existing Other Agreement) with any Person for any term in any voting and non-redemption agreement entered into in connection with such Other Agreement that is more favorable to such Person than the corresponding term in this Agreement, then Seller shall promptly (and in any event within five (5) business days) provide Buyer with written notice thereof together with a copy of such Other Agreement or amendment, and Buyer shall thereupon be entitled (exercisable by written notice to Seller within ten (10) business days of receipt of such notice, in Buyer's sole discretion) to elect to have the corresponding terms of this Agreement amended (with retroactive effect to the date hereof) to incorporate such more favorable terms.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;14. <u>Specific Performance</u>. The parties agree that irreparable damage would occur if any provision of this Agreement were not performed in accordance with the terms hereof and that the parties shall be entitled to seek specific performance of the terms hereof, in addition to any other remedy to which they are entitled at law or in equity.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;15. <u>Cumulative Remedies</u>. The rights and remedies provided in this Agreement cumulative and are in addition to and not in substitution for any other rights and remedies available at law or in equity or otherwise.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;16. <u>No Third-Party Beneficiaries</u>. Except as provided in <u>Section 17</u>, **t**his Agreement is for the sole benefit of the parties hereto and their respective successors and permitted assigns, and nothing herein, express or implied, is intended to or shall confer upon any other Person any legal or equitable right, benefit, or remedy of any nature whatsoever under or by reason of this Agreement.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;17. <u>Releases</u>.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(a) Each of the SPAC, the Seller, ReserveOne and R-1 Holdings, generally releases and discharges each of the Buyer and its predecessors, successors (by merger or otherwise), parents, subsidiaries, Affiliates and assigns, together with each and every of their respective present, past and future officers, directors, shareholders, employees, representatives and agents and the family members, heirs and executors of same (collectively referred to herein as the "**Buyer Parties**") from any and all claims, actions, causes of action, demands, liens, agreements, contracts, covenants, actions, suits, causes of action, obligations, promises, controversies, complaints, debts, dues, costs, expenses, damages, judgments, orders and liabilities, of whatever kind or nature, direct or indirect, in law, equity or otherwise, whether known or unknown ("**Claims**"), that each of the SPAC, the Seller, ReserveOne and R-1 Holdings ever had now has against the Buyer or any other member of the Buyer Parties arising out of or in connection with the (i) Subscription Agreements dated as of July 7, 2025, by and among ReserveOne, R-1 Holdings, the SPAC and the Buyer (the "**Subscription Agreements**"), (ii) Business Combination Agreement and (iii) termination of any of the foregoing, including, without limitation, any and all Claims for attorneys' fees and costs with respect to the released Claims; <u>provided</u> that the foregoing is not intended to and shall not have the effect of limiting the ability of the SPAC, the Seller, ReserveOne and R-1 Holdings to enforce this Agreement.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b) The Buyer generally releases and discharges each of the SPAC, the Seller, ReserveOne and R-1 Holdings and each of their predecessors, successors (by merger or otherwise), parents, subsidiaries, Affiliates and assigns, together with each and every of their respective present, past and future officers, directors, shareholders, employees, representatives and agents and the family members, heirs and executors of the same (collectively referred to herein as the "**Seller Parties**") from any and all Claims that the Buyer ever had or now has against each of the SPAC, the Seller, ReserveOne and R-1 Holdings or any other member of the Seller Parties arising out of or in connection with the (i) Subscription Agreements, (ii) Business Combination Agreement, and (iii) termination of any of the foregoing, including, without limitation, any and all Claims for attorneys' fees and costs with respect to the released Claims; <u>provided</u> that the foregoing is not intended to and shall not have the effect of limiting the ability of the Buyer to enforce this Agreement.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(c) Each party represents and warrants that it has not heretofore transferred or assigned, or purported to transfer or assign, to any person, firm, or corporation, any Claims, actions, suit, proceeding, governmental investigation or exchange inquiry, liabilities or indemnities herein released. Each party further represents and warrants that neither it nor any assignee has filed any lawsuit against any other party.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;18. <u>Representations and Warranties of the SPAC, the Seller, ReserveOne and R-1 Holdings</u>. Except as otherwise specified below in this <u>Section 18</u>, each of the SPAC, the Seller, ReserveOne and R-1 Holdings, severally and not jointly, represents and warrants to, and agrees with, the Buyer that:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(a) **<u>Power and Authority</u>**. Such party is the type of entity indicated in the preamble to this Agreement and is duly formed and validly existing and in good standing as such type of entity under the laws of the place of its formation and possesses all requisite entity power and authority to enter into this Agreement and to perform all of the obligations required to be performed by it hereunder.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b) **<u>Authority</u>**. All corporate action on the part of such party and its officers, directors and members necessary for the authorization, execution and delivery of this Agreement and the performance of all obligations of such party required pursuant hereto has been taken. This Agreement has been duly executed and delivered by such party and (assuming due authorization, execution and delivery by the Buyer) constitutes such party's legal, valid and binding obligation, enforceable against such party in accordance with its terms, except as such enforceability may be limited by applicable bankruptcy, insolvency, fraudulent conveyance, moratorium, reorganization, or similar laws relating to, or affecting generally the enforcement of, creditors' rights and remedies or by equitable principles of general application and except as enforcement of rights to indemnity and contribution may be limited by federal and state securities laws or principles of public policy.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(c) **<u>Title to Transferred Warrants.</u>** The Seller is the record and beneficial owner of, and has good and marketable title to, the Transferred Warrants and will, immediately prior to the transfer of the Transferred Warrants to the Buyer, be the record and beneficial owner of the Transferred Warrants, in each case, free and clear of all Encumbrances other than the Permitted Encumbrances. The Transferred Warrants are duly authorized, validly issued, fully paid and non-assessable. The Transferred Warrants to be transferred, when transferred to the Buyer as provided herein, will be free and clear of all Encumbrances other than the Permitted Encumbrances.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(d) **<u>No Conflicts</u>**. The execution, delivery and performance of this Agreement and the consummation by such party of the transactions contemplated hereby do not violate, conflict with or constitute a default under (i) such party's governing documents, (ii) any agreement or instrument to which such party is a party or by which it is bound or (iii) any law, statute, rule or regulation to which such party is subject or any order, judgment or decree to which such party is subject. Such party is not required under federal, state or local law, rule or regulation to obtain any consent, authorization or order of, or make any filing or registration with, any court or governmental agency or self-regulatory entity in order for it to perform any of its obligations under this Agreement in accordance with the terms hereof.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(e) **<u>No General Solicitation</u>**. The Seller has not offered the Transferred Warrants by means of any general solicitation or general advertising within the meaning of Regulation D of the Securities Act, including but not limited to any advertisement, article, notice or other communication published in any newspaper, magazine, or similar media or broadcast over television or radio or any seminar or meeting whose attendees have been invited by any general solicitation or general advertising.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(f) **<u>Brokers</u>**. No broker, finder or intermediary has been paid or is entitled to a fee or commission from or by such party in connection with the sale of the Transferred Warrants nor is such party entitled to or will accept any such fee or commission.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(g) **<u>Transfer Restrictions</u>**. Until the earlier of the (i) transfer of the Private Placement Warrants pursuant to the terms hereof or (ii) termination of this Agreement, the Seller agrees that it will not Transfer the Transferred Warrants or any interest therein or right referencing or related thereto, to any person or entity.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(h) **<u>No Pending Actions</u>**. There is no action pending against such party or, to such party's knowledge, threatened against such party or the other parties hereto, before any court, arbitrator, or governmental authority, which in any manner challenges or seeks to prevent, enjoin or materially delay the performance by such party of its obligations under this Agreement

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(i) **<u>Reliance on Representations and Warranties</u>**. Such party understands and acknowledges that the Buyer is relying upon the truth and accuracy of the representations, warranties, agreements, acknowledgments and understandings of such party set forth in this Agreement.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;19. <u>Governing Law</u>. All matters arising out of or relating to this Agreement and all related documents shall be governed by and construed in accordance with the internal laws of the State of New York without giving effect to any choice or conflict of law provision.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;20. <u>Submission to Jurisdiction</u>. Any legal suit, action, proceeding, or dispute arising out of or related to this Agreement or the transactions contemplated hereby may be instituted only in the federal courts of the United States of America or the courts of the State of New York, in each case located in the Borough of Manhattan in New York City, State of New York, and each party irrevocably submits to the exclusive jurisdiction of such courts in any such suit, action, proceeding, or dispute. EACH OF THE PARTIES HERETO HEREBY AGREES TO WAIVE ANY RIGHT TO TRIAL BY JURY WITH RESPECT TO ANY CLAIM, COUNTERCLAIM OR ACTION ARISING OUT OF OR RELATING TO THIS AGREEMENT.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;21. <u>Expenses</u>. Except as otherwise specifically stated herein, all costs and expenses incurred in connection with this Agreement and the transactions contemplated hereby shall be paid by the party incurring such costs and expenses.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;22. <u>C</u><u>ounterparts</u>. This Agreement may be executed in any number of counterparts, including by electronic transmission, each of which shall be deemed an original but all of which together shall constitute the same instrument.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;23. <u>Waiver Against Trust</u>. The Buyer hereby agrees, on behalf of itself and the other members of the Buyer Parties, that, notwithstanding anything to the contrary in this Agreement, solely in its capacity as a holder of Transferred Warrants (and not in its capacity as a holder of any Class A Shares constituting Public Shares), neither the Buyer nor any other member of the Buyer Parties shall have or shall at any time thereafter have any Claim of any kind in or to any monies in the Trust Account or distributions therefrom, or make any Claim against the Trust Account (including any distributions therefrom), regardless of whether such Claim arises as a result of, in connection with or relating in any way to, this Agreement or any proposed or actual business relationship between the Seller, the SPAC, ReserveOne, R-1 Holdings or their respective Affiliates, on the one hand, and the Buyer or its Affiliates, on the other hand, or any other matter, and regardless of whether such Claim arises based on contract, tort, equity or any other theory of legal liability (collectively, the "**Trust Released Claims**"). The Buyer, on behalf of itself and the other member of the Buyer Parties, hereby irrevocably waives any Trust Released Claims that the Buyer or any other member of the Buyer Parties may have against the Trust Account (including any distributions therefrom) now or in the future and will not seek recourse against the Trust Account (including any distributions therefrom) for any reason whatsoever (including for an alleged breach of this Agreement or any other agreement with Buyer, Seller, the SPAC, ReserveOne, R-1 Holdings or their respective Affiliates). The Buyer agrees and acknowledges that such irrevocable waiver by it is material to this Agreement and specifically relied upon by the Seller and its Affiliates to induce it to enter into this Agreement, and the Buyer further intends and understands such waiver to be valid, binding and enforceable against the Buyer and each other member of the Buyer Parties under applicable law. Notwithstanding anything to the contrary in this <u>Section 22</u>, the foregoing waiver shall not limit, waive, release, or otherwise affect the Buyer's right (in its capacity as a public shareholder of the SPAC) to receive (i) pro-rata distributions from the Trust Account in respect of any Class A Shares constituting Public Shares in connection with any redemption of such Class A Shares constituting Public Shares pursuant to the SPAC's organizational documents or in connection with the dissolution or liquidation of the SPAC, and (ii) any distributions in respect of any termination fee, expense reimbursement, or similar payment received by the SPAC from any third party that is, by the terms of such payment or by operation of the SPAC's organizational documents or the Trust Agreement, payable to or distributable among the holders of Class A Shares generally, provided that no provision of this <u>Section 22</u> shall limit any obligation of the Buyer pursuant to <u>Section 4</u> of this Agreement or any separate non-redemption agreement.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;24. <u>Confidentiality</u>. Notwithstanding anything in this Agreement to the contrary, each of the SPAC, the Seller, ReserveOne and R-1 Holdings (i) shall not publicly disclose the name of Buyer or any of its Affiliates or advisers, or include the name of Buyer or any of its Affiliates or advisers in any press release, without the prior written consent of Buyer and (ii) shall not publicly disclose the name of Buyer or any of its Affiliates or advisers, or include the name of Buyer or any of its Affiliates or advisers in any filing with the SEC any regulatory agency or trading market, without the prior written consent of Buyer, except to the extent such disclosure is required by other laws, rules or regulations, or at the request of the staff of the SEC or other regulatory agency, in which case the SPAC shall provide Buyer with prior written notice (including by e-mail) of such permitted disclosure, and shall reasonably consult with Buyer regarding such disclosure. Buyer will promptly provide any information reasonably requested by the SPAC for any regulatory application or filing made or approval sought in connection with the transactions contemplated by this Agreement.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;25. <u>Termination</u>. This Agreement shall terminate on the earliest of (i) the failure of the SPAC's shareholders to approve the Amendments on or prior to August 2, 2026, (ii) the liquidation or dissolution of the SPAC, (iii) the mutual written agreement of the parties hereto, or (iv) the failure of the Business Combination Agreement to be terminated as of the date hereof pursuant to the BCA Termination Agreement. Upon termination of this Agreement, all rights and obligations of the parties hereunder shall terminate without any further liability on the part of any party in respect thereof; provided that <u>Sections 14 – 17</u> and <u>19-24</u> shall survive any such termination in accordance with their respective terms; and provided further that nothing herein will relieve any party from liability for any willful and material breach hereof prior to the time of termination, and each party will be entitled to any remedies at law or in equity to recover losses, liabilities or damages arising from such breach. In addition, upon termination of this Agreement, the Registration Rights Joinder, the Letter Agreement Joinder and the Warrant Assignment which the Buyer has executed shall be null and void and of no further force and effect.

 

*[Remainder of page intentionally left blank; signature pages follow]*

 

IN WITNESS WHEREOF, ReserveOne and R-1 Holdings have executed this Agreement as of the date first above written.

---

| | |
|:---|:---|
| **<u>RESERVEONE</u>:** | **<u>RESERVEONE</u>:** |
| **RESERVEONE, INC.** | **RESERVEONE, INC.** |
| By: |  |
| Name: | Jaime Leverton |
| Title: | Chief Executive Officer |
| **<u>R-1 HOLDINGS</u>:** | **<u>R-1 HOLDINGS</u>:** |
| **RESERVEONE HOLDINGS, INC.** | **RESERVEONE HOLDINGS, INC.** |
| By: |  |
| Name: | Jaime Leverton |
| Title: | Chief Executive Officer |

---

*[Signature Page to Voting Support and Non-Redemption Agreement]*

IN WITNESS WHEREOF, the SPAC has executed this Agreement as of the date first above written.

---

| |
|:---|
| **<u>SPAC</u>:** |
| **M3-BRIGADE ACQUISITION V CORP.** |
| By: |
| Name: |
| Title: |

---

*[Signature Page to Voting Support and Non-Redemption Agreement]*

IN WITNESS WHEREOF, the Seller has executed this Agreement as of the date first above written.

---

| | |
|:---|:---|
| **<u>SELLER</u>:** | **<u>SELLER</u>:** |
| **MI7 SPONSOR, LLC** | **MI7 SPONSOR, LLC** |
| By: |  |
| Name: | Thomas Boychuk |
| Title: | Chief Financial Officer |

---

*[Signature Page to Voting Support and Non-Redemption Agreement]*

IN WITNESS WHEREOF, the Buyer has executed or caused this Agreement to be executed by its duly authorized representative as of the date first above written.

---

| |
|:---|
| **<u>BUYER</u>**: |
| **[__________]** |
| By: |
| Name: |
| Title: |

---

**Buyer Shares:** 

__________ Class A Shares

**Transferred Warrants:**

__________ Private Placement Warrants

*[Signature Page to Voting Support and Non-Redemption Agreement]*

**<u>Schedule A</u>**

**<u>Deferred Liabilities</u>**

[\*\*\*]

*[Schedule A to Voting Support and Non-Redemption Agreement]*

**<u>Exhibit I</u>**

**<u>Form of Charter Amendment</u>**

[\*\*\*]

## Exhibit 10.6

**Exhibit 10.6**

**JOINDER AGREEMENT**

This Joinder Agreement (the "***Joinder Agreement***"), dated as of June 12, 2026, is executed by and between M3-Brigade Acquisition V Corp., a Cayman Islands exempted company (the "***Company***"), and the counterparty designated as "Buyer" in the signature page hereto ("***Buyer***"), in connection with that certain Registration Rights Agreement, dated as of July 31, 2024 (the "***Agreement***"), by and among the Company, MI7 Sponsor, LLC, a Delaware limited liability company (as assignee of M3-Brigade Sponsor V LLC) (the "***Sponsor***"), Cantor Fitzgerald & Co., and each person who has become a party thereto by entering into a joinder agreement in accordance with the terms thereof. Capitalized terms used but not defined herein shall have the meaning given to such terms in the Agreement.

By the execution of this Joinder Agreement, Buyer agrees as follows:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;1. Buyer is a party to that certain Voting Support and Non-Redemption Agreement, dated as of June 12, 2026, by and among the Sponsor, Buyer, the Company, ReserveOne, Inc. and ReserveOne Holdings, Inc. (the "**NRA**"), pursuant to which the Sponsor has agreed to transfer to Buyer a number of the Sponsor's private placement warrants issued by the Company (the "**Private Placement Warrants**") as set forth on the signature page of the NRA. The transferred Private Placement Warrants will be "Registrable Securities" as such term is defined in the Agreement.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;2. Upon the transfer of the Private Placement Warrants to Buyer, without any further action required, Buyer hereby automatically joins in, and agrees to become a party to and be bound by and subject to, the provisions of the Agreement, solely with respect to the Private Placement Warrants transferred to Buyer.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;3. Any notice required or permitted by the Agreement shall be given to Buyer at the address listed below its name on the signature page hereto.

[*Remainder of Page Left Intentionally Blank*]

IN WITNESS WHEREOF, the undersigned has executed this Joinder Agreement as of the date set forth above.

---

| |
|:---|
| **BUYER:** |
| **[______________]** |
| By: |
| Name: |
| Title: |
| Address: |

---

---

| |
|:---|
| **ACKNOWLEDGED AND AGREED:** |
| **M3-BRIGADE ACQUISITION V CORP.** |
| By: |
| Name: |
| Title: |
| **CANTOR FITZGERALD & CO.** |
| By: |
| Name: |
| Title: |

---

*[Signature Page to Joinder Agreement to Registration Rights Agreement (Private Placement Warrants)]*

## Exhibit 10.7

**Exhibit 10.7**

**JOINDER AGREEMENT**

This Joinder Agreement (the "***Joinder Agreement***"), dated as of June 12, 2026, is executed by and between M3-Brigade Acquisition V Corp., a Cayman Islands exempted company (the "***Company***"), and the counterparty designated as "Buyer" in the signature page hereto ("***Buyer***"), in connection with that certain Letter Agreement, dated as of July 31, 2024 (the "***Agreement***"), by and among the Company, MI7 Sponsor, LLC, a Delaware limited liability company (as assignee of M3-Brigade Sponsor V LLC) (the "***Sponsor***"), the other parties thereto, and each person who has become a party thereto by entering into a joinder agreement in accordance with the terms thereof. Capitalized terms used but not defined herein shall have the meaning given to such terms in the Agreement.

By the execution of this Joinder Agreement, Buyer agrees as follows:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;1. Buyer is a party to that certain Voting Support and Non-Redemption Agreement, dated as of June 12, 2026, by and among the Sponsor, Buyer, the Company, ReserveOne, Inc. and ReserveOne Holdings, Inc. (the "**NRA**"), pursuant to which the Sponsor has agreed to transfer to Buyer a number of Sponsor's private placement warrants issued by the Company (the "***Private Placement Warrants***") as set forth on the signature page of the NRA.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;2. Upon the transfer of the Private Placement Warrants to Buyer, without any further action required, Buyer hereby automatically joins in, and agrees to become a party to and be bound by and subject to, the provisions set forth in Subsections 7(b) and (c) of the Agreement applicable to the Sponsor, solely as such terms relate to the transfer of the Private Placement Warrants. For the avoidance of doubt, Buyer shall not be subject to the provisions of the Agreement with respect to any Offering Shares (as defined in the Agreement) that it may own.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;3. The undersigned hereby acknowledge and agree that upon the transfer of the Private Placement Warrants, Buyer shall be bound only by Subsections 7(b) and (c) of the Agreement, solely to the extent such provisions relate to the Private Placement Warrants and for the avoidance of doubt, Buyer shall not be subject to any other provision of the Agreement, and no provision of the Agreement shall apply to any Offering Shares that it may own.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;4. Each of the Company and the Sponsor represent and warrant to Buyer that each of the Company and the Sponsor have obtained all consents, approvals, waivers or authorizations required to be obtained from any individual, corporation, partnership, joint venture, limited liability company, governmental authority, unincorporated organization, trust, association, or other entity in connection with the limited joinder contemplated hereby and the matters contemplated herein.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;5. Any notice required or permitted by the Agreement shall be given to Buyer at the address listed below its name on the signature page hereto.

[*Remainder of Page Left Intentionally Blank*]

IN WITNESS WHEREOF, the undersigned has executed this Joinder Agreement as of the date set forth above.

---

| |
|:---|
| **BUYER:** |
| **[______________]** |
| By: |
| Name: |
| Title: |
| Address: |

---

*[Signature Page to Joinder Agreement – Letter Agreement (Private Placement Warrants)]*

---

| |
|:---|
| **ACKNOWLEDGED AND AGREED:** |
| **MI7 SPONSOR, LLC** |
| By: |
| Name: |
| Title: |
| **M3-BRIGADE ACQUISITION V CORP.** |
| By: |
| Name: |
| Title: |

---

*[Signature Page to Joinder Agreement – Letter Agreement (Private Placement Warrants)]*

## Exhibit 10.8

**Exhibit 10.8**

**VOTING SUPPORT AGREEMENT**

THIS VOTING SUPPORT AGREEMENT (this "**Agreement**"), dated as of June 12, 2026, is made and entered into by and among the undersigned shareholder (the "**Shareholder**") and M3-Brigade Acquisition V Corp., a Cayman Islands exempted company incorporated with limited liability (the "**SPAC**").

Unless otherwise stated herein, capitalized terms used in this Agreement shall have the meanings ascribed to them in the prospectus relating to the registration statement on Form S-1 of M3-Brigade Acquisition V Corp. first filed with the U.S. Securities and Exchange Commission (the "**SEC**") on June 5, 2024 (Registration No. 333-279951), as amended and as declared effective on July 31, 2024, and as may be supplemented or post-effectively amended from time to time.

**RECITALS**

**WHEREAS**, the SPAC was incorporated on March 12, 2024, and consummated an initial public offering of its units on August 2, 2024, generating gross proceeds of $287,500,000 (the "**IPO**");

**WHEREAS**, the Class A ordinary shares, par value $0.0001 per share, of the SPAC constituting Public Shares ("**Class A Shares**"), and associated warrants to purchase Class A Shares ("**Listed Warrants**"), and units of the SPAC are listed on The Nasdaq Stock Market LLC ("**Nasdaq**") under the trading symbols "MBAV", "MBAVW" and "MBAVU", respectively;

**WHEREAS**, the SPAC intends to amend the SPAC's Amended and Restated Memorandum and Articles of Association (the "**Articles**") substantially in the form attached hereto as <u>Exhibit I</u> (the "**Charter Amendment**");

**WHEREAS**, the SPAC intends to amend the Investment Management Trust Agreement by and between the SPAC and Continental Stock Transfer & Trust Co., as trustee (the "**Trustee**"), dated as of July 31, 2024 (the "**Trust Agreement**") to incorporate provisions for the release of interest from the SPAC's trust account ("**Trust Account**") as permitted by the Charter Amendment (the "**Trust Amendment**" and together with the Charter Amendment, the "**Amendments**");

**WHEREAS**, the Shareholder and the SPAC desire to enter into this Agreement whereby the Shareholder agrees, among other things, to vote the Voting Shares (as defined herein) in favor of the proposed Amendments; and

**WHEREAS,** as consideration for the Shareholder to enter into this Agreement, the SPAC agrees to pay the Shareholder a total aggregate amount of ten dollars ($10);

**NOW, THEREFORE**, in consideration of the mutual covenants and agreements hereinafter set forth and for other good and valuable consideration, the receipt and sufficiency of which are hereby acknowledged, the parties hereto, intending to be legally bound by the terms hereof, agree as follows:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;1. <u>Shareholder's Ownership</u>. The Shareholder represents and warrants that, as of the date hereof, it is the "beneficial owner" (as defined in Rule 13d-3 under the Securities Exchange Act of 1934, as amended (the "**Exchange Act**")) of the number of Class A Shares set forth on the signature page hereto (the "**Voting Shares**"). Furthermore, the Shareholder represents and warrants that as of the date hereof, the Shareholder and its Affiliates own the Voting Shares, which shares are subject to the covenants set forth in this Agreement, whether or not such shares are "beneficially owned" under the Exchange Act. For purposes of this Agreement, (i) the term "**Affiliate**" or "**Affiliates**" of a Person means any other Person that directly or indirectly, through one or more intermediaries, controls, is controlled by, or is under common control with, such Person, (ii) the term "**control**" (including the terms "controlled by" and "under common control with") means the possession, directly or indirectly, of the power to direct or cause the direction of the management and policies of a Person, whether through the ownership of voting securities, by contract, or otherwise, and (iii) the term "**Person"** means an individual, corporation, partnership, joint venture, limited liability company, governmental authority, unincorporated organization, trust, association, or other entity.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;2. <u>Covenant to Vote</u>. In consideration of the terms of this Agreement, with respect to all Class A Shares owned by the Shareholder and its Affiliates as of and through the record date for any meeting of SPAC's shareholders, solely in their respective capacity as a shareholder of the SPAC, at any meeting of the SPAC's shareholders, or in any other meeting or circumstance in which the vote, consent or other approval of the SPAC's shareholders is sought to approve the Amendments (and any such meeting, a "**Covered Meeting**"), the Shareholder and its Affiliates hereby irrevocably agree that if a meeting is held, to be present for any such meeting, and to vote (in person or by proxy), or, if voting is permitted by written consent, to execute and deliver a written consent covering, all Class A Shares owned by the Shareholder and its Affiliates in favor of the Amendments and cause all such shares to be counted as present thereat for purposes of establishing a quorum. For the avoidance of doubt, nothing in this Agreement shall be construed to require Shareholder and its Affiliates to vote in favor of any other proposal other than the Amendments.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;3. <u>Matters Related to Voting Commitment</u>. In consideration of the terms of this Agreement, the Shareholder further agrees, with respect to all Class A Shares owned as of the date hereof or hereafter acquired by the Shareholder or its Affiliates, solely in their respective capacity as a shareholder of the SPAC, during the period from, and including, the date hereof through, and including, the record date with respect to the Covered Meeting (the "**Record Date**") :

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(a) not to deposit, and to cause its Affiliates not to deposit, any such Class A Shares in a voting trust or subject any such Class A Shares to any arrangement or agreement with respect to the voting of such Class A Shares, unless specifically requested to do so by the SPAC; and

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b) not to make, or in any manner participate in, directly or indirectly, a "solicitation" of "proxies" or consents (as such terms are used in the rules of the SEC) or powers of attorney or similar rights to vote, or seek to advise or influence any Person with respect to the voting of any capital shares of the SPAC in connection with any vote or other action with respect to the Amendments, other than to recommend that shareholders of the SPAC vote in favor of the Amendments and any other proposal the approval of which is a condition to the obligations of the parties hereunder.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;4. <u>No Hedging or Transfers of the Voting Shares</u>. The Shareholder covenants and agrees that neither it, nor any Person or entity acting on its behalf or pursuant to any understanding with it, will, from the execution of this Agreement and through the Record Date: (i) engage in any hedging transactions or Short Sales (as defined herein) with respect to securities of the SPAC, (ii) offer for sale, sell (including Short Sales), transfer (including by operation of law), place a lien on, pledge, convert, assign or otherwise dispose of (including by gift, merger, tendering into any tender offer or exchange offer or otherwise) or encumber (collectively, a "**Transfer"**), or enter into any contract, option, derivative, hedging or other agreement, arrangement, undertaking or understanding (including any profit-sharing arrangement) with respect to, or consent to, a direct or indirect Transfer of, any or all of the Voting Shares, and any other Class A Shares owned by the Shareholder and its Affiliates, or (iii) take any action that would have the effect of preventing or materially delaying the performance of its obligations hereunder. Notwithstanding anything to the contrary in this <u>Section 4</u>, in the event that (1) any meeting of the SPAC's shareholders is held in which the vote, consent or other approval of the SPAC's shareholders is sought to approve the Amendments (and such meeting is not adjourned prior to any vote to approve the Amendments being taken) and the Amendments are not approved by the requisite vote of the SPAC's shareholders, or (2) the effectiveness of the Amendments does not occur by 11:59 p.m. EST on August 2, 2026, then any restrictions on the Transfer of the Voting Shares in the this <u>Section 4</u> shall have no further force or effect. For purposes of this Agreement, "**Short Sales**" shall include, without limitation, (A) all "short sales" as defined in Rule 200 promulgated under Regulation SHO under the Exchange Act, (B) all types of direct and indirect stock pledges (other than pledges in the ordinary course of business as part of prime brokerage or other similar financing arrangements), forward sale contracts, options, puts, calls, swaps and similar arrangements (including on a total return basis), and (C) sales and other transactions through non-U.S. broker dealers or foreign regulated brokers.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;5. <u>Charter Amendments</u>. The terms of the Charter Amendment include the following:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(a) extending the date by which the SPAC must consummate an initial business combination by 12 months (to August 2, 2027);

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b) permitting the SPAC, following the effective date of the Amendments after all redemptions pursuant to the exercise of redemption rights arising in connection with the Amendments have been settled, to withdraw up to an aggregate amount of interest earned on the funds held in the Trust Account in an amount equal to $0.10 for each Class A Share issued in the IPO that is not redeemed and remains outstanding immediately following the effective date of the Amendments, of which (i) $1,000,000 will be used to pay expenses incurred by the SPAC in the ordinary course, including without limitation with respect to legal, accounting, printing, insurance, trust and stock transfer services, not in excess of $1,000,000 in the aggregate (the "**Ordinary Course Expenses**") and (ii) any amounts in excess of such $1,000,000 will be used to pay the accrued expenses that are due and payable as of the effective date of the Amendments (the "**Covered Expenses**");

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(c) changing the SPAC's legal name to Velos Acquisition I Corp.;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(d) removing Article 49.12 (fairness opinion requirement) from the Articles in its entirety; and

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(e) such other modifications to the Articles as may be necessary to give effect to amendments (a) – (d).

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;6. <u>Grant of Proxy</u>. In the event that the Shareholder fails to vote its Class A Shares by proxy by the date that is one (1) business day prior to the date of the Covered Meeting, the Shareholder hereby grants to the SPAC, and any individual designated in writing by the SPAC, a proxy and power of attorney (with full power of substitution and resubstitution) for and in such Shareholder's name, solely to vote all Class A Shares owned by the Shareholder in favor of the Amendments in the manner contemplated by <u>Section 2</u>. Such proxy shall be coupled with an interest, irrevocable, shall be limited to curing the Shareholder's voting obligations with respect to the Amendments and shall expire automatically upon shareholder approval of the Amendments.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;7. <u>Specific Performance</u>. The parties agree that irreparable damage would occur if any provision of this Agreement were not performed in accordance with the terms hereof and that the parties shall be entitled to seek specific performance of the terms hereof, in addition to any other remedy to which they are entitled at law or in equity.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;8. <u>Cumulative Remedies</u>. The rights and remedies provided in this Agreement cumulative and are in addition to and not in substitution for any other rights and remedies available at law or in equity or otherwise.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;9. <u>No Third-Party Beneficiaries</u>. This Agreement is for the sole benefit of the parties hereto and their respective successors and permitted assigns, and nothing herein, express or implied, is intended to or shall confer upon any other Person any legal or equitable right, benefit, or remedy of any nature whatsoever under or by reason of this Agreement.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;10. <u>Governing Law</u>. All matters arising out of or relating to this Agreement and all related documents shall be governed by and construed in accordance with the internal laws of the State of New York without giving effect to any choice or conflict of law provision.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;11. <u>Submission to Jurisdiction</u>. Any legal suit, action, proceeding, or dispute arising out of or related to this Agreement or the transactions contemplated hereby may be instituted only in the federal courts of the United States of America or the courts of the State of New York, in each case located in the Borough of Manhattan in New York City, State of New York, and each party irrevocably submits to the exclusive jurisdiction of such courts in any such suit, action, proceeding, or dispute. EACH OF THE PARTIES HERETO HEREBY AGREES TO WAIVE ANY RIGHT TO TRIAL BY JURY WITH RESPECT TO ANY CLAIM, COUNTERCLAIM OR ACTION ARISING OUT OF OR RELATING TO THIS AGREEMENT.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;12. <u>Expenses</u>. Except as otherwise specifically stated herein, all costs and expenses incurred in connection with this Agreement and the transactions contemplated hereby shall be paid by the party incurring such costs and expenses.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;13. <u>C</u><u>ounterparts</u>. This Agreement may be executed in any number of counterparts, including by electronic transmission, each of which shall be deemed an original but all of which together shall constitute the same instrument.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;14. <u>Waiver Against Trust</u>. The Shareholder hereby agrees that, notwithstanding anything to the contrary in this Agreement (other than as a holder of any Class A Shares constituting Public Shares) the Shareholder shall not have nor shall it at any time thereafter have any claim, action, causes of action, demands, liens, agreements, suits, controversies, complaints, and orders, of whatever kind in nature, direct or indirect, in law, equity or otherwise, whether known or unknown ("**Claim**") of any kind in or to any monies in the Trust Account or distributions therefrom, or make any Claim against the Trust Account (including any distributions therefrom), regardless of whether such Claim arises as a result of, in connection with or relating in any way to, this Agreement or any proposed or actual business relationship between the SPAC, on the one hand, and the Shareholder or its Affiliates, on the other hand, or any other matter, and regardless of whether such Claim arises based on contract, tort, equity or any other theory of legal liability (collectively, the "**Trust Released Claims**"). The Shareholder, on behalf of itself its Affiliates, hereby irrevocably waives any Trust Released Claims that the Shareholder or any of its Affiliates may have against the Trust Account (including any distributions therefrom) now or in the future and will not seek recourse against the Trust Account (including any distributions therefrom) for any reason whatsoever (including for an alleged breach of this Agreement or any other agreement with the SPAC or its Affiliates). The Shareholder agrees and acknowledges that such irrevocable waiver by it is material to this Agreement and specifically relied upon by the SPAC and its Affiliates, to induce it to enter into this Agreement, and the Shareholder further intends and understands such waiver to be valid, binding and enforceable against the Shareholder and its Affiliates under applicable law. Notwithstanding anything to the contrary in this <u>Section 14</u>, the foregoing waiver shall not limit, waive, release, or otherwise affect the Shareholder's right (in its capacity as a public shareholder of the SPAC) to receive (i) pro-rata distributions from the Trust Account in respect of any Class A Shares constituting Public Shares in connection with any redemption of such Class A Shares constituting Public Shares pursuant to the SPAC's organizational documents or in connection with the dissolution or liquidation of the SPAC, and (ii) any distributions in respect of any termination fee, expense reimbursement, or similar payment received by the SPAC from any third party that is, by the terms of such payment or by operation of the SPAC's organizational documents or the Trust Agreement, payable to or distributable among the holders of Class A Shares generally, provided that no provision of this <u>Section 14</u> shall limit any obligation of the Shareholder pursuant to any separate non-redemption agreement.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;15. <u>Confidentiality</u>. Notwithstanding anything in this Agreement to the contrary, the SPAC shall not publicly disclose the name of the Shareholder or any of its Affiliates or advisers, or include the name of the Shareholder or any of its Affiliates or advisers in any press release, without the prior written consent of the Shareholder and (ii) shall not publicly disclose the name of the Shareholder or any of its Affiliates or advisers, or include the name of the Shareholder or any of its Affiliates or advisers in any filing with the SEC, any regulatory agency or trading market, without the prior written consent of the Shareholder, except to the extent such disclosure is required by other laws, rules or regulations, or at the request of the staff of the SEC or other regulatory agency, in which case the SPAC shall provide the Shareholder with prior written notice (including by e-mail) of such permitted disclosure, and shall reasonably consult with the Shareholder regarding such disclosure. The Shareholder will promptly provide any information reasonably requested by the SPAC for any regulatory application or filing made or approval sought in connection with the transactions contemplated by this Agreement.

 

*[Remainder of page intentionally left blank; signature pages follow]*

 

IN WITNESS WHEREOF, the SPAC has executed this Agreement as of the date first above written.

---

| |
|:---|
| **<u>SPAC</u>**: |
| **M3-BRIGADE ACQUISITION V CORP.** |
| By: |
| Name: |
| Title: |

---

 

*[Signature Page to Voting Support Agreement]*

IN WITNESS WHEREOF, the Shareholder has executed this Agreement as of the date first above written.

**[●]** 

By: 

Name: 

Title: 

**Voting Shares:** 

__________ Class A Shares

*[Signature Page to Voting Support Agreement]*

**<u>Exhibit I</u>**

**<u>Form of Charter Amendment</u>**

[Attached]

## Exhibit 99.1

**Exhibit 99.1**

**M3-Brigade Acquisition V Corp. Announces Cancellation of Extraordinary General Meeting of Shareholders to Approve Business Combination**

NEW YORK, June 12, 2026 /PR Newswire/ – M3-Brigade Acquisition V Corp. (Nasdaq: MBAV) (the "**Company**"), a special purpose acquisition company, today announced that it has cancelled its extraordinary general meeting of shareholders (the "**Meeting**") to consider and vote on the previously announced proposed business combination (the "**Business Combination**") between the Company and ReserveOne, Inc., a Delaware corporation ("**ReserveOne**").

The Meeting, which was originally scheduled to be held on June 15, 2026, at 11:00 a.m. Eastern Time, and which was later postponed to June 18, 2026 at 12:00 p.m. Eastern Time, has been cancelled by the Company's board of directors and will not occur. The Company has cancelled the meeting due to its entry into a Mutual Termination Agreement (the "**Termination Agreement**") between the Company and ReserveOne, Inc., ("**ReserveOne**") pursuant to which the parties agreed to mutually terminate the Business Combination Agreement, dated as of July 7, 2025 (the "**BCA**") by and among (i) the Company, (ii) ReserveOne, (iii) ReserveOne Holdings, Inc., a wholly owned subsidiary of ReserveOne ("**Pubco**"), (iv) R1 SPAC Merger Sub, Inc., a wholly owned subsidiary of Pubco, and (v) R1 Company Merger Sub, Inc., a wholly owned subsidiary of Pubco, pursuant to Section 7.1(a) of the BCA (other than certain customary limited provisions that survive the termination pursuant to the terms of the BCA), effective June 12, 2026.

Since the announcement of the proposed merger between ReserveOne and the Company in July 2025, market conditions impacting the digital asset sector have changed significantly. Following careful consideration of current market dynamics and feedback from investors and other stakeholders, ReserveOne, Inc. and the Company have mutually agreed to terminate the BCA.

In connection with the termination of the Business Combination and the BCA, the Company is entering into various agreements described below in order provide the Company with additional time to identify and complete a business combination as well as funding for working capital and payment of certain liabilities.

**Mutual Termination Agreement**

On June 12, 2026, the Company and ReserveOne entered into the Termination Agreement, pursuant to which the parties agreed to mutually terminate the BCA, pursuant to Section 7.1(a) of the BCA (other than certain customary limited provisions that survive the termination pursuant to the terms of the BCA) effective June 12, 2026. By virtue of the termination of the BCA, each of the Equity PIPE Subscription Agreements, the Convertible Notes Subscription Agreements and the Sponsor Support Agreement (each as defined in the BCA) (the Equity PIPE Subscription Agreements and the Convertible Notes Subscription Agreements, together the "**Subscription Agreements**") terminated in accordance with their respective terms.

**Securities Purchase Agreement**

On June 12, 2026, the Company entered into Securities Purchase Agreements (collectively, the "**Securities Purchase Agreements**") with MI7 Sponsor, LLC, a Delaware limited liability company and the sponsor of the Company (the "**Sponsor**"), ReserveOne, Pubco and certain investors (collectively, the "**Investors**") named therein. Pursuant to the Securities Purchase Agreements, upon the effectiveness of the Amendments (as defined below), among other things, the Sponsor has agreed to sell, and the Investors have agreed to purchase up to an aggregate of 4,279,279 Class A ordinary shares, par value $0.0001 per share, of the Company (the "**Class A Shares**,") issuable upon the conversion of the Sponsor's Class B ordinary shares, par value $0.0001 (the "**Class B Shares**"), which pursuant to the Securities Purchase Agreements, the Sponsor has agreed to convert to Class A Shares and which the parties have agreed to continue to treat as "Founder Shares" as described in the Securities Purchase Agreements. The Investors will purchase these Class A Shares for a price per share equal to $3.33 (such purchased shares, the "**Transferred Shares**") resulting in aggregate gross proceeds to the Sponsor of $14,250,000. Each of the Investors has deposited an amount equal to the purchase price for the Transferred Shares it agreed to purchase into an escrow account with funds to be released upon the closing of the transactions contemplated by the Securities Purchase Agreements (the "**Transaction**").

Contemporaneously with the execution of the Securities Purchase Agreements:

● the Company and ReserveOne entered into the Termination Agreement;

● the Company and the Investors entered into Joinder Agreements (the "**Transferred Shares Registration Rights Joinders**") to that certain Registration Rights Agreement, dated as of July 31, 2024, by and among the Company, the Sponsor and Cantor Fitzgerald & Co. (the "**Registration Rights Agreement** "), pursuant to which, among other things, (i) the Transferred Shares will be "Registrable Securities" as such term is defined in the Registration Rights Agreement; and (ii) upon the transfer of the Transferred Shares to the Investors, each Investor will join in, and agree to become a party to and be bound by and subject to, certain provisions of the Registration Rights Agreement with respect to the Transferred Shares; and

● the Company, the Sponsor and the Investors entered into Joinder Agreements (the "**Transferred Shares Letter Agreement Joinders**") to that certain Letter Agreement, dated as of July 31, 2024 (the "**Letter Agreement** "), pursuant to which, among other things, upon the transfer of the Transferred Shares to the Investors, each Investor will join in, and agree to become a party to and be bound by and subject to, the provisions set forth in Sections 1, 2, 6, 7, 11, and 13 through 20 of the Letter Agreement applicable to the Sponsor as such terms relate to the transfer of the Transferred Shares.

The closing of the Transaction shall take place upon the effective date of certain contemplated amendments to the Company's Amended and Restated Memorandum and Articles of Association (the "**Articles**") (as discussed below), subject to the closing conditions, that (i) the Termination Agreement continues to be in full force and effect and has not been rescinded, withdrawn, or otherwise become ineffective, and (ii) the termination of the Subscription Agreements continues to be in full force and effect and has not been rescinded, withdrawn, or otherwise become ineffective.

The Securities Purchase Agreements contain mutual releases by the Company, the Sponsor, ReserveOne and Pubco, on the one hand, and the Investors, on the other hand, for all claims known and unknown, arising out of or in connection with (i) the Subscription Agreements, (ii) the BCA, and (iii) the termination of any of the foregoing. If the transactions contemplated by the Securities Purchase Agreements have not closed on or before August 2, 2026, the Investors may terminate their respective Securities Purchase Agreements and receive a return of their funds held in escrow, in accordance with the terms of the Securities Purchase Agreements.

Contemporaneously with the execution and delivery of the Securities Purchase Agreements, ReserveOne, Pubco and the Company requested the Securities and Exchange Commission's (the "**SEC**") consent to withdraw the Registration Statement on Form S-4 (Registration No. 333-279951) declared effective by the SEC on May 13, 2026.

A portion of the net proceeds from the sale of the Transferred Shares is expected to be used by the Sponsor to make one or more loans to the Company up to an aggregate of $4,000,000 for purposes of paying "**Covered Expenses**" (as defined in the Securities Purchase Agreements), which consist of accrued expenses of the Company that are due and payable by the Company as of the closing of the Transaction.

**Shareholder Meeting**

The Company intends, as promptly as practicable after the execution of the Securities Purchase Agreements, to prepare and file with the SEC a proxy statement for the purpose of soliciting proxies from the Company's shareholders to approve, at an extraordinary general meeting of the Company's shareholders (the "**Shareholder Meeting**"), amendments to its Articles, to, among other things: (i) extend the date by which the Company must consummate an initial business combination by 12 months (from August 2, 2026 to August 2, 2027); (ii) permit the Company, following the effective date of the amendments after all redemptions pursuant to the exercise of redemption rights arising in connection with the amendments have been settled, to withdraw up to an aggregate amount of interest earned on the funds held in the Company's trust account in an amount equal to $0.10 for each Class A Share issued in the Company's initial public offering that is not redeemed and remains outstanding immediately following the effective date of the amendments, of which (a) $1,000,000 will be used to fund working capital and pay certain ordinary course expenses of the Company and (b) any amounts in excess of such $1,000,000 will be used to pay Covered Expenses; (iii) change the Company's legal name to Velos Acquisition I Corp.; (iv) remove Article 49.12 (the fairness opinion requirement) from the Articles in its entirety; and (v) such other modifications to the Articles as may be necessary to give effect to amendments (i) – (iv) (such amendments to the Articles, the "**Amendments**" and such proposals to be presented at the Shareholder Meeting, the "**Amendment Proposals**").

**Voting and Non-Redemption Agreements**

On June 12, 2026, the Company, the Sponsor, ReserveOne and Pubco entered into Voting Support and Non-Redemption Agreements (the "**Voting and Non-Redemption Agreements**") with certain investors (such investors entering the Voting and Non-Redemption Agreements, collectively, the "**Voting and Non-Redemption Shareholders**") pursuant to which the Voting and Non-Redemption Shareholders have agreed not to redeem up to an aggregate of 16,000,000 Class A Shares in connection with the Shareholder Meeting. Pursuant to the Voting and Non-Redemption Agreements, the Voting and Non-Redemption Shareholders have agreed to vote in favor of the Amendment Proposals. The Voting and Non-Redemption Agreements provide that the Sponsor will transfer up to an aggregate of approximately 8,000,000 private placement warrants (the "**Private Placement Warrants**") held by the Sponsor to the Voting and Non-Redemption Shareholders in consideration for the Voting and Non-Redemption Shareholders' agreement to hold and not redeem their Class A Shares in connection with the Shareholder Meeting.

Contemporaneously with the execution of the Voting and Non-Redemption Agreements:

● the Company and ReserveOne entered into the Termination Agreement;

● the Company and the Voting and Non-Redemption Shareholders entered into Joinder Agreements (the "**Private Placement Registration Rights Joinders**") to the Registration Rights Agreement, pursuant to which, among other things, (i) the transferred Private Placement Warrants will be "Registrable Securities" as such term is defined in the Registration Rights Agreement; and (ii) upon the transfer of the Private Placement Warrants to the Voting and Non-Redemption Shareholders, each Voting and Non-Redemption Shareholder will join in, and agree to become a party to and be bound by and subject to, certain provisions of the Registration Rights Agreement with respect to the Private Placement Warrants; and

● the Company, the Sponsor and the Voting and Non-Redemption Shareholders entered into Joinder Agreements (the "**Private Placement Letter Agreement Joinders**") to the Letter Agreement, pursuant to which, among other things, upon the transfer of the Private Placement Warrants to the Voting and Non-Redemption Shareholders, each Voting and Non-Redemption Shareholder will join in, and agree to become a party to and be bound by and subject to, the provisions set forth in Section 7 of the Letter Agreement applicable to the Sponsor as such terms relate to the transfer of the Private Placement Warrants.

The Voting and Non-Redemption Agreements contain mutual releases by the Company, the Sponsor, ReserveOne and Pubco, on the one hand, and the Voting and Non-Redemption Shareholders, on the other hand, for all claims known and unknown, arising out of or in connection with the Equity PIPE Subscription Agreements and/or the Convertible Notes Subscription Agreements.

**Voting Agreements**

On June 12, 2026, the Company, the Sponsor, ReserveOne and Pubco entered into Voting Support Agreements (the "**Voting Agreements**") with certain unaffiliated third parties (collectively, the "**Voting Shareholders**") pursuant to which the Voting Shareholders agreed to vote in favor of the Amendment Proposals.

**About M3-Brigade Acquisition V Corp.**

M3-Brigade Acquisition V Corp. (NASDAQ: MBAVU, MBAV, MBAVW) is a special purpose acquisition company formed to identify and partner with companies undergoing transformational growth, with a focus on innovative platforms in the digital, energy, and infrastructure sectors. It is sponsored by MI7 Sponsor, LLC, an affiliate of CC Capital, which also owns ReserveOne.

**Cautionary Statement Regarding Forward-Looking Statements**

Certain statements herein and the documents incorporated herein by reference may constitute "forward-looking statements", which statements involve inherent risks and uncertainties.

Examples of forward-looking statements include, but are not limited to, statements with respect to the termination of the BCA; the ability of the Company to enter into an alternative business combination transaction; expectations concerning the Securities Purchase Agreements, the Transferred Shares Registration Rights Joinders, the Transferred Shares Letter Agreement Joinders, the Voting and Non-Redemption Agreements, the Private Placement Registration Rights Joinders, the Private Placement Letter Agreement Joinders and the Voting Agreements (the "**Alternative Agreements**") and the transactions and activities contemplated thereunder; plans and expectations related to the Shareholder Meeting; the approval by the Company's shareholders of the Amendment Proposals, and the Amendments; and the Company's, ReserveOne's and Pubco's expectations, intentions, strategies, assumptions or beliefs about future events, results at operations or performance or that do not solely relate to historical or current facts.

These forward-looking statements generally are identified by the words "believe," "project," "expect," "anticipate," "estimate," "intend," "strategy," "future," "opportunity," "potential," "plan," "may," "should," "will," "would," "will be," "will continue," "will likely result," and similar expressions. Forward-looking statements are based on assumptions as of the time they are made and are subject to risks, uncertainties and other factors that are difficult to predict with regard to timing, extent, likelihood and degree of occurrence, which could cause actual results to differ materially from anticipated results expressed or implied by such forward-looking statements. Such risks, uncertainties and assumptions, include, but are not limited to: (i) the failure by the parties to satisfy the conditions to the consummation of the Alternative Agreements; (ii) the risk that the Amendment Proposals are not approved by the Company's shareholders; (iii) the risk that the Company may not be able to complete an alternative business combination transaction in a timely manner, or at all; (iv) risks related to the Company's anticipated business plans and strategies to implement an alternative business combination; (v) the outcome of any potential legal proceedings that may be instituted against the Company; (vi) the failure of the Company to maintain the listing of its securities on any stock exchange on which its securities trade; (vii) costs related to the Alternative Agreements or an alternative business combination; (viii) changes in business, market, financial, political and regulatory conditions, including as a result of wars, political violence, global pandemics, trade and monetary policies, or other macroeconomic events; (ix) being considered to be a "shell company" by any stock exchange or by the SEC; and (x) those risk factors discussed in documents of the Company filed, or to be filed, with the SEC.

The foregoing list of risk factors is not exhaustive. You should carefully consider the foregoing factors and the other risks and uncertainties described in the "Risk Factors" section in the Company's Annual Report on Form 10-K for the fiscal year ended December 31, 2025, our Quarterly Reports on Form 10-Q, and other documents filed or to be filed by the Company from time to time with the SEC. These filings do or will identify and address other important risks and uncertainties that could cause actual events and results to differ materially from those contained in the forward-looking statements. There may be additional risks that neither the Company, ReserveOne or Pubco presently know or currently believe are immaterial that could also cause actual results to differ from those contained in the forward-looking statements.

Forward-looking statements speak only as of the date they are made. Readers are cautioned not to put undue reliance on forward-looking statements, and except as otherwise required by applicable law, none of the parties or any of their representatives assumes any obligation and does not intend to update or revise these forward-looking statements, whether as a result of new information, future events, or otherwise. None of the parties or any of their representatives gives any assurance that any of the Company, ReserveOne or Pubco will achieve its expectations. The inclusion of any statement in this press release does not constitute an admission by ReserveOne, Pubco, the Company or any other person that the events or circumstances described in such statement are material.

**Contacts**

**M3-Brigade Acquisition V Corp.**

c/o M3 Partners, LP

1700 Broadway

19th Floor

New York, NY 10019

T: 212-202-2200

www.m3-brigade.com

Investor Relations:

Sodali & Co.

333 Ludlow Street, 5<sup>th</sup> Floor

Stamford, CT 06902

Attn: M&A and Activism Advisory Group

Toll Free Telephone: (800) 662-5200

Main Telephone: (203) 658-9400

Email: MBAV@info.sodali.com

**Media Contact:**

Kate Thompson / Erik Carlson / Alexander Wolfsohn

Joele Frank, Wilkinson Brimmer Katcher

+1 (212) 355-4449

CC-Capital-JF@joelefrank.com

Eric Andrus / Andrew Frank

KARV

+1 (212) 333 0275

Email: CC-Capital@KARV.global